Tokushima University / Educator and Researcher Directory --- Matsuura, Tomomi

Field of Study

Subject of Study

Book / Paper

Book:

1.	Tomomi Matsuura : 血圧上昇・ショック (Chapter 1 症候), Ishiyaku Publishers,Inc., Tokyo, May 2014.

Academic Paper (Judged Full Paper):

1.	Yutaka Kawabata, Tetsuzo Wakatsuki, Koji Yamaguchi, Daiju Fukuda, Hiroyuki Ito, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Y Tsuruo and Masataka Sata : Association of Microluminal Structures Assessed by Optical Coherence Tomography With Local Inflammation in Adjacent Epicardial Adipose Tissue and Coronary Plaque Characteristics in Fresh Cadavers, Circulation Journal, Vol.87, No.2, 329-335, 2023. (Summary) Coronary intraplaque microluminal structures (MS) are associated with plaque vulnerability, and the inward progression of vascular inflammation from the adventitia towards the media and intima has also been demonstrated. Therefore, in the present study we investigated the relationships among MS, local inflammation in adjacent epicardial adipose tissue (EAT), and coronary plaque characteristics.Methods and Results: Optical coherence tomography (OCT) revealed MS in the left anterior descending coronary artery in 10 fresh cadaveric hearts. We sampled 30 lesions and subdivided them based on the presence of MS: MS (+) group (n=19) and MS (-) group (n=11). We measured inflammatory molecule levels in the adjacent EAT and percentage lipid volume assessed by integrated backscatter intravascular ultrasound in each lesion. The expression levels of vascular endothelial growth factor B and C-C motif chemokine ligand 2 were significantly higher in the MS (+) group than in the MS (-) group (0.9±0.7 vs. 0.2±0.2 arbitrary units (AU), P=0.04 and 1.5±0.5 vs. 0.6±0.7 AU, P=0.02, respectively). Percentage lipid volume was significantly higher in the MS (+) group than in the MS (-) group (38.7±16.5 vs. 23.7±10.9%, P=0.03). Intraplaque MS observed on OCT were associated with lipid-rich plaques and local inflammation in the adjacent EAT. Collectively, these results suggest that local inflammation in the EAT is associated with coronary plaque vulnerability via MS. (Tokushima University Institutional Repository) ● Metadata: 117602 (Link to Publication Site) ● Publication site (DOI): 10.1253/circj.CJ-22-0299 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 36244741 ● Search Scopus @ Elsevier (PMID): 36244741 ● Search Scopus @ Elsevier (DOI): 10.1253/circj.CJ-22-0299 (Tokushima University Institutional Repository: 117602, DOI: 10.1253/circj.CJ-22-0299, PubMed: 36244741)
2.	O Bavuu, Daiju Fukuda, B Ganbaatar, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : Esaxerenone, a selective mineralocorticoid receptor blocker, improves insulin sensitivity in mice consuming high-fat diet., European Journal of Pharmacology, 175190, 2022. (Summary) Esaxerenone is a novel, non-steroidal selective mineralocorticoid receptor (Csige et al.) blocker. MR activation plays a crucial role in the development of cardiovascular and metabolic diseases. In this study, we investigated the effects of esaxerenone on various metabolic parameters in mice. Esaxerenone (3 mg/kg/day) was orally administered to high-fat diet (HFD)-fed male C57BL/6 mice. Mice fed a normal diet (ND) served as controls. Glucose and insulin tolerance, plasma lipid levels, and transaminase levels were assessed as metabolic parameters. Macrophage accumulation in the adipose tissue was evaluated using histological analysis. 3T3-L1 adipocytes, HepG2 cells, and C2C12 myotubes were used for in vitro experiments. Gene expression and insulin signaling were examined using quantitative RT-PCR and western blotting, respectively. HFD successfully induced insulin resistance compared with that in ND. Esaxerenone ameliorated insulin resistance (P < 0.05) without altering other metabolic parameters, such as the lipid profile. Esaxerenone administration tended to decrease plasma transaminase levels compared with those in the non-treated group. In the adipose tissue, esaxerenone decreased macrophage accumulation (P < 0.05) and increased the expression levels of adiponectin and PPARγ. Aldosterone significantly decreased the expression levels of PPARγ and adiponectin in 3T3-L1 adipocytes. Furthermore, aldosterone attenuated insulin-induced Akt phosphorylation in 3T3-L1 adipocytes, HepG2 cells, and C2C12 myotubes in a dose-dependent manner (P < 0.01). These effects were ameliorated by pretreatment with esaxerenone. Esaxerenone ameliorated insulin resistance in HFD-fed mice. Reduction of inflammation and improvement in insulin signaling may underlie the beneficial effects of esaxerenone. (Tokushima University Institutional Repository) ● Metadata: 117375 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.ejphar.2022.175190 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35961594 ● Search Scopus @ Elsevier (PMID): 35961594 ● Search Scopus @ Elsevier (DOI): 10.1016/j.ejphar.2022.175190 (Tokushima University Institutional Repository: 117375, DOI: 10.1016/j.ejphar.2022.175190, PubMed: 35961594)
3.	Koji Yamaguchi, Tetsuzo Wakatsuki, Tomomi Matsuura, Kazuhisa Matsumoto, Yutaka Kawabata, Muneyuki Kadota, Kenya Kusunose, Takayuki Ise, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Drug-coated balloon angioplasty for severe pulmonary vein stenosis resulting from cryoballoon ablation for atrial fibrillation, Journal of Cardiology Cases, Vol.26, 35-38, 2022. (Tokushima University Institutional Repository) ● Metadata: 117234 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jccase.2022.02.009 (Link to Search Site for Scientific Articles) ● Summary page in Scopus @ Elsevier: 2-s2.0-85127324683 (Tokushima University Institutional Repository: 117234, DOI: 10.1016/j.jccase.2022.02.009, Elsevier: Scopus)
4.	Yasuhiro Mitsui, Mai Yagi, Sho Muraki, Tomomi Matsuura, Yoshimi Bando, Shota Fujimoto, Shinji Kitamura, Koichi Okamoto, Naoki Muguruma, Masataka Sata and Tetsuji Takayama : Pulmonary Tumor Thrombotic Microangiopathy Due to Gastric Cancer Diagnosed Antemortem by a Cytological Examination of Aspirated Pulmonary Artery Blood., Internal Medicine, Vol.61, No.10, 1491-1495, 2022. (Tokushima University Institutional Repository) ● Metadata: 118012 (Link to Publication Site) ● Publication site (DOI): 10.2169/internalmedicine.8313-21 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34670901 ● Search Scopus @ Elsevier (PMID): 34670901 ● Search Scopus @ Elsevier (DOI): 10.2169/internalmedicine.8313-21 (Tokushima University Institutional Repository: 118012, DOI: 10.2169/internalmedicine.8313-21, PubMed: 34670901)
5.	Kazuhisa Matsumoto, Takeshi Tobiume, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Tetsuzo Wakatsuki, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Evaluation of the input site and characteristics of the antegrade fast pathway based on three-dimensional bi-atrial stimulus-ventricle mapping, Journal of Interventional Cardiac Electrophysiology, Vol.63, No.2, 417-424, 2022. (Summary) Previous studies examined the right atrial (RA) input site of the antegrade fast pathway (AFp) (AFpI). However, the left atrial (LA) input to the atrioventricular (AV) node has not been extensively evaluated. In this study, we created three-dimensional (3-D) bi-atrial stimulus-ventricle (St-V) maps and analyzed the input site and characteristics of the AFp in both the RA and LA. Forty-four patients diagnosed with atrial fibrillation or WPW syndrome were included in this study. Three-dimensional bi-atrial St-V mapping was performed using an electroanatomical mapping system. Sites exhibiting the minimal St-V interval (MinSt-V) were defined as AFpIs and were classified into seven segments, four in the RA (F, S, M, and I) and three in the LA (M1, M2, and M3). By combining the MinSt-V in the RA and LA, the AFpIs were classified into three types: RA, LA, and bi-atrial (BA) types. The clinical and electrophysiological characteristics were compared. AFpIs were most frequently observed at site S in the RA (34%) and M2 in the LA (50%), and the BA type was the most common (57%). AFpIs in the LA were recognized in 75% of the patients. There were no clinical or electrophysiological indicators for predicting AFpI sites. Three-dimensional bi-atrial St-V maps could classify AFpIs in both the RA and LA. AFpIs in the LA were frequently recognized. There were no significant clinical or electrophysiological indicators for predicting AFpI sites, and 3-D bi-atrial St-V mapping was the only method to reveal the precise AFp input site. (Tokushima University Institutional Repository) ● Metadata: 116382 (Link to Publication Site) ● Publication site (DOI): 10.1007/s10840-021-01026-7 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34231099 ● Search Scopus @ Elsevier (PMID): 34231099 ● Search Scopus @ Elsevier (DOI): 10.1007/s10840-021-01026-7 (Tokushima University Institutional Repository: 116382, DOI: 10.1007/s10840-021-01026-7, PubMed: 34231099)
6.	Shusuke Yagi, Daiju Fukuda, Takayuki Ise, Koji Yamaguchi, Kenya Kusunose, Muneyuki Kadota, Yutaka Kawabata, Tomomi Matsuura, Tomohiro Soga, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Shinji Kawahito and Masataka Sata : Clinical clerkship students' preferences and satisfaction regarding online lectures during the COVID-19 pandemic, BMC Medical Education, Vol.22, No.1, 43, 2022. (Summary) The COVID-19 pandemic has caused an unprecedented disruption in medical education. Students and lecturers had to adapt to online education. The current study aimed to investigate the level of satisfaction and future preference for online lectures among clinical clerkship students and elucidated the factors that affect these outcomes. We selected a sample of 114 medical students undergoing clinical clerkship during the COVID-19 pandemic. We conducted onsite lectures before the pandemic and online lectures after the outbreak. A survey was conducted, and the sample included students and 17 lecturers. The average scores of total satisfaction and future preference related to online lectures were computed. Students' scores on total satisfaction with online lectures and their future preference were higher than those for onsite lectures. Scores on the ease of debating dimension were low and those on accessibility of lectures in online lectures were higher than those in onsite lectures. There was no difference between the two groups in the scores on the comprehensibility and ease of asking questions dimensions. Results of the multiple regression analysis revealed that accessibility determined total satisfaction, and future preference was determined by comprehensibility as well as accessibility. Contrary to students' future preferences, lecturers favored onsite lectures to online ones. Online lectures are an acceptable mode of teaching during the COVID-19 pandemic for students undergoing clinical clerkship. Online lectures are expected to become more pervasive to avoid the spread of COVID-19. (Keyword) COVID-19 / Clinical Clerkship / Humans / Pandemics / Personal Satisfaction / SARS-CoV-2 / Students, Medical (Tokushima University Institutional Repository) ● Metadata: 116989 (Link to Publication Site) ● Publication site (DOI): 10.1186/s12909-021-03096-7 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35042505 ● Summary page in Scopus @ Elsevier: 2-s2.0-85123015852 (Tokushima University Institutional Repository: 116989, DOI: 10.1186/s12909-021-03096-7, PubMed: 35042505, Elsevier: Scopus)
7.	Nao Ishii, Kenya Kusunose, A Shono, K Matsumoto, Susumu Nishio, Natsumi Yamaguchi, Yukina Hirata, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : Effects of Radiofrequency Catheter Ablation on Cardiac Reserve Using Preload Stress Echocardiography in Paroxysmal and Persistent Atrial Fibrillation, The American Journal of Cardiology, Vol.168, 71-77, 2022. (Summary) The effects of catheter ablation on exercise tolerance and quality of life in patients with atrial fibrillation (AF) have been reported. We assessed cardiac function in more detail using the leg positive pressure (LPP) technique and found that contractile reserve is particularly important in relation to exercise tolerance and prognosis. In this study, we used the LPP technique to examine changes in contractile reserve immediately after ablation and 6 months later. We prospectively enrolled patients who underwent catheter ablation for AF at 2 institutes. We performed LPP stress echocardiography 2 to 3 days after (FU-1) and 6 months after (FU-2) ablation to examine changes in cardiac function indexes. The primary end point was improvement in contractile reserve. Ultimately, 109 patients (mean age 67.4 ± 9.6 years; 70% men) underwent 2 sessions of LPP stress echocardiography. The median CHADS-VAS score was 2 (interquartile range 13). From FU-1 to FU-2, the change in the stroke volume index after the LPP maneuver increased in patients with paroxysmal and persistent AF with low CHADS-VAS scores (both p <0.05). Regardless of AF subtype, contractile reserve at FU-2 improved in patients with low CHADS-VAS scores compared with that at FU-1. In contrast, patients with high CHADS-VAS scores had no change. In conclusion, patients with AF with a low CHADS-VAS score had improved contractile reserve after ablation, whereas patients with high scores did not show any improvement. Aggressive interventions in patients with high scores may lead to better management after catheter ablation. (Keyword) Aged / Atrial Fibrillation / Catheter Ablation / Echocardiography, Stress / Female / Humans / Male / Middle Aged / Predictive Value of Tests / Quality of Life / Risk Assessment / Risk Factors / Treatment Outcome (Tokushima University Institutional Repository) ● Metadata: 116987 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.amjcard.2021.12.026 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35063270 ● Search Scopus @ Elsevier (PMID): 35063270 ● Search Scopus @ Elsevier (DOI): 10.1016/j.amjcard.2021.12.026 (Tokushima University Institutional Repository: 116987, DOI: 10.1016/j.amjcard.2021.12.026, PubMed: 35063270)
8.	Shusuke Yagi, T Takahashi, K Murakami, M Azuma, M Sugano, R Miyamoto, M Niki, Hirotsugu Yamada, Yutaka Kawabata, Tani Akihiro, Daiju Fukuda, Muneyuki Kadota, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Tomomi Matsuura, Koji Yamaguchi, Takeshi Soeki, Tetsuzo Wakatsuki, H Hata and Masataka Sata : Infective Endocarditis from Furuncle with Meningitis Complication Caused by Methicillin-resistant Staphylococcus aureus, Internal Medicine, Vol.60, No.20, 3251-3255, 2021. (Tokushima University Institutional Repository) ● Metadata: 118014 (Link to Publication Site) ● Publication site (DOI): 10.2169/internalmedicine.6902-20 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33867390 ● Search Scopus @ Elsevier (PMID): 33867390 ● Search Scopus @ Elsevier (DOI): 10.2169/internalmedicine.6902-20 (Tokushima University Institutional Repository: 118014, DOI: 10.2169/internalmedicine.6902-20, PubMed: 33867390)
9.	Tomomi Matsuura, Takeshi Soeki, Daiju Fukuda, Etsuko Uematsu, Takeshi Tobiume, Tomoya Hara, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : Activated Factor X Signaling Pathway via Protease-Activated Receptor 2 Is a Novel Therapeutic Target for Preventing Atrial Fibrillation, Circulation Journal, Vol.85, No.8, 1383-1391, 2021. (Summary) Activated factor X (FXa), which contributes to chronic inflammation via protease-activated receptor 2 (PAR2), might play an important role in atrial fibrillation (AF) arrhythmogenesis. This study aimed to assess whether PAR2 signaling contributes to AF arrhythmogenesis and whether rivaroxaban ameliorates atrial inflammation and prevents AF.Methods and Results:In Study 1, PAR2 deficient (PAR2-/-) and wild-type mice were infused with angiotensin II (Ang II) or a vehicle via an osmotic minipump for 2 weeks. In Study 2, spontaneously hypertensive rats (SHRs) were treated with rivaroxaban, warfarin, or vehicle for 2 weeks after 8 h of right atrial rapid pacing. The AF inducibility and atrial remodeling in both studies were examined. Ang II-treated PAR2-/- mice had a lower incidence of AF and less mRNA expression of collagen1 and collagen3 in the atrium compared to wild-type mice treated with Ang II. Rivaroxaban significantly reduced AF inducibility compared with warfarin or vehicle. In SHRs treated with a vehicle, rapid atrial pacing promoted gene expression of inflammatory and fibrosis-related biomarkers in the atrium. Rivaroxaban, but not warfarin, significantly reduced expression levels of these genes. The FXa-PAR2 signaling pathway might contribute to AF arrhythmogenesis associated with atrial inflammation. A direct FXa inhibitor, rivaroxaban, could prevent atrial inflammation and reduce AF inducibility, probably by inhibiting the pro-inflammatory activation. (Tokushima University Institutional Repository) ● Metadata: 116065 (Link to Publication Site) ● Publication site (DOI): 10.1253/circj.CJ-20-1006 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33746155 ● Summary page in Scopus @ Elsevier: 2-s2.0-85111576585 (Tokushima University Institutional Repository: 116065, DOI: 10.1253/circj.CJ-20-1006, PubMed: 33746155, Elsevier: Scopus)
10.	Yutaka Kawabata, Takeshi Soeki, Hiroyuki Ito, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Takeshi Tobiume, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki, M Kitani, K Kawano, Y Taketani and Masataka Sata : Effects of L-/N-Type Calcium Channel Blockers on Angiotensin II-Renin Feedback in Hypertensive Patients, International Journal of Hypertension, 6653851, 2020. (Tokushima University Institutional Repository) ● Metadata: 115937 (Link to Publication Site) ● Publication site (DOI): 10.1155/2020/6653851 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33489354 ● Summary page in Scopus @ Elsevier: 2-s2.0-85098701678 (Tokushima University Institutional Repository: 115937, DOI: 10.1155/2020/6653851, PubMed: 33489354, Elsevier: Scopus)
11.	Takeshi Tobiume, R Kato, Tomomi Matsuura, Kazuhisa Matsumoto, M Hara, N Takamori, Y Taketani, K Okwa, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki, Takeshi Soeki, Masataka Sata and K Matsumoto : Antegrade slow pathway mapping of typical atrioventricular nodal reentrant tachycardia based on direct slow pathway capture, Journal of Arrhythmia, Vol.37, No.1, 128-139, 2020. (Tokushima University Institutional Repository) ● Metadata: 116343 (Link to Publication Site) ● Publication site (DOI): 10.1002/joa3.12484 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33664895 ● Summary page in Scopus @ Elsevier: 2-s2.0-85099515348 (Tokushima University Institutional Repository: 116343, DOI: 10.1002/joa3.12484, PubMed: 33664895, Elsevier: Scopus)
12.	Hiroyuki Ito, Tetsuzo Wakatsuki, Koji Yamaguchi, Daiju Fukuda, Yutaka Kawabata, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Yoshihiro Tsuruo and Masataka Sata : Atherosclerotic Coronary Plaque Is Associated With Adventitial Vasa Vasorum and Local Inflammation in Adjacent Epicardial Adipose Tissue in Fresh Cadavers, Circulation Journal, Vol.84, No.5, 769-775, 2020. (Tokushima University Institutional Repository) ● Metadata: 116640 (Link to Publication Site) ● Publication site (DOI): 10.1253/circj.CJ-19-0914 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 32281556 ● Summary page in Scopus @ Elsevier: 2-s2.0-85083919450 (Tokushima University Institutional Repository: 116640, DOI: 10.1253/circj.CJ-19-0914, PubMed: 32281556, Elsevier: Scopus)
13.	Shusuke Yagi, Daisuke Kondo, Takayuki Ise, Daiju Fukuda, Koji Yamaguchi, Tetsuzo Wakatsuki, Yutaka Kawabata, Hiroyuki Ito, Yoshihito Saijo, Hiromitsu Seno, Kumiko Sutou, Rie Ueno, Takafumi Todoroki, Kenya Kusunose, Tomomi Matsuura, Takeshi Tobiume, Hirotsugu Yamada, Takeshi Soeki, Michio Shimabukuro, Ken-ichi Aihara, Masashi Akaike and Masataka Sata : Association of Decreased Docosahexaenoic Acid Level After Statin Therapy and Low Eicosapentaenoic Acid Level with In-Stent Restenosis in Patients with Acute Coronary Syndrome, Journal of Atherosclerosis and Thrombosis, Vol.26, No.3, 272-281, 2019. (Summary) It is speculated that statin therapy modulates the synthesis of polyunsaturated fatty acids (PUFA), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). However, the data available on the effects of statin therapy on the serum levels of PUFA and the subsequent impact on in-stent restenosis (ISR) in patients with acute coronary syndrome (ACS) are limited. A total of 120 ACS patients who received emergent coronary stent implantation, follow-up coronary angiography to evaluate ISR, and new statin therapy were enrolled. We measured the serum levels of the PUFA and lipids at the onset of ACS and at the follow-up coronary angiography. The follow-up coronary angiography revealed 38 ISR cases. New statin therapy significantly reduced the serum levels of DHA and low-density lipoprotein cholesterol (LDL-C), while it did not affect EPA level. Single regression analysis revealed that a decreased serum level of LDL-C was associated with decreased DHA level. The multiple logistic regression analysis revealed that the decreased DHA level after statin therapy and low serum level of EPA on admission were determinants of prevalence of ISR. Statin therapy decreased the serum level of DHA with a parallel reduction in LDL-C level in patients with ACS. Decreased DHA level after statin therapy and low EPA level on admission are risk factors for ISR, indicating that in patients with ACS, decreased serum levels of DHA may be a residual target for the prevention of ISR. (Keyword) Acute Coronary Syndrome / Aged / Coronary Restenosis / Docosahexaenoic Acids / Eicosapentaenoic Acid / female / Follow-Up Studies / Humans / Hydroxymethylglutaryl-CoA Reductase Inhibitors / male / Prognosis / Retrospective Studies / Risk Factors / Stents (Tokushima University Institutional Repository) ● Metadata: 113220 (Link to Publication Site) ● Publication site (DOI): 10.5551/jat.44735 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 30135329 ● Summary page in Scopus @ Elsevier: 2-s2.0-85062425735 (Tokushima University Institutional Repository: 113220, DOI: 10.5551/jat.44735, PubMed: 30135329, Elsevier: Scopus)
14.	Mina Takahashi, Takeshi Tobiume, Kazuhisa Matsumoto, Tomomi Matsuura, Takeshi Soeki, 藤本裕太, 原田貴文, Zengu Robahto, 數藤久美子, 西條良仁, 上野理絵, Yutaka Kawabata, Mika Bando, nao Yamada, Hiroyuki Ito, 轟貴史, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : A successful case of catheter ablation against ventricular tachycardia storm due to old myocardial infarction in a patient with aortic valve replacement, Shikoku Acta Medica, Vol.74, No.56, 201-208, 2019. (Summary) A 68-year-old woman with VT storm and frequent appropriate ICD therapy was referred for catheter ablation. Her past history was notable for aortic valve replacement by mechanical valve due to infectious endocarditis 17 years prior to presentation and left ventricular apical old myocardial infarction with unknown onset. At 67 years old, She admitted to the prior hospital due to ventricular tachycardia with LBBB and superior axis at heart rate of 210 per minutes. Administration of amiodarone and magnesium sulfate was ineffective and cardioversion of 200J was successfully terminated the tachycardia. Intra-cardiac defibrillator was implanted and the administration of amiodarone and mexiletine was started. 5 months after, she admitted to the hospital due to the frequent appropriate shock against the same ventricular tachycardia. Administration of lidocaine, sotalol, pilsicainide, and magnesium sulfate could not control the tachycardia and she was referred to our hospital for catheter ablation. During the first session, ventricular tachycardia was easily induced and electroanatomical mapping was performed both during tachycardia and during sinus rhythm. Late diastolic potential preceding the onset of QRS wave by 45ms was detected at the infero-septal side of the apical aneurysm. 7 5s of the RF energy application at this site could terminate the tachycardia and thereafter no ventricular tachycardia was induced. But after dose-reduction or cessation of some anti-arrhythmic drugs, ventricular tachycardia was recurred and second session was performed. This time, no ventricular tachycardia was induced, then we performed isthmus transection and core isolation against the apical aneurysm. Thereafter no ventricular tachycardia was occurred in spite of dose-reduction or cessation of some anti-arrhythmic drugs. (Keyword) ventricular tachycardia / storm / old myocardial infarction / catheter ablation / aortic valve replacement (Tokushima University Institutional Repository) ● Metadata: 112988 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050001338015711104 (Tokushima University Institutional Repository: 112988, CiNii: 1050001338015711104)
15.	Shusuke Yagi, Rie Ueno, Kumiko Sutou, Tetsuzo Wakatsuki, Koji Yamaguchi, Yoshihito Saijo, Tomoya Hara, Takayuki Ise, Kenya Kusunose, Mika Bando, Tomomi Matsuura, Takeshi Tobiume, Hirotsugu Yamada, Daiju Fukuda, Takeshi Soeki, Masashi Akaike and Masataka Sata : Lambda-like J wave due to acute myocardial infarction of the diagonal branch, The Journal of Medical Investigation : JMI, Vol.66, No.1,2, 185-187, 2019. (Summary) The culprit lesion of acute myocardial infarction could be predicted by electrocardiogram findings. However, we experienced some cases with coronary angiographic finding in the area of ST-T elevation that was different from that predicted. The lambda-like J wave could be caused by ischemia although the mechanism has not been fully elucidated. We report a case of acute myocardial infarction that showed discrepancy between ST-T elevation with lambda-like ischemic J wave in a broad area and coronary angiographical finding of diagonal branch occlusion. J. Med. Invest. 66 : 185-187, February, 2019. (Tokushima University Institutional Repository) ● Metadata: 113420 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.66.185 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31064936 ● Summary page in Scopus @ Elsevier: 2-s2.0-85065772885 (Tokushima University Institutional Repository: 113420, DOI: 10.2152/jmi.66.185, PubMed: 31064936, Elsevier: Scopus)
16.	Yoshihito Saijo, Hirotsugu Yamada, Kenya Kusunose, Mika Bando, Susumu Nishio, Yuta Torii, Yukina Hirata, Hiromitsu Seno, Tomomi Matsuura, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : A clinical application of preload stress echocardiography for predicting future hemodynamic worsening in patients with early-stage heart failure., Echocardiography, Vol.35, No.10, 1587-1595, 2018. (Summary) To improve the prognosis of patients with heart failure, risk stratification in their early stage is important. We assessed whether the change in transmitral flow (TMF) velocity pattern during preload augmentation can predict future hemodynamic worsening in early-stage heart failure patients with impaired relaxation TMF pattern. We designed a prospective cohort study that included 155 consecutive patients with impaired relaxation (IR) pattern at rest. Preload stress echocardiography was achieved using leg-positive pressure (LPP), and changes in TMF pattern during the LPP was observed during baseline echocardiographic examination. The patients whose TMF pattern developed to pseudonormal (PN) pattern throughout the study period were classified into the change to PN group, and patients whose TMF pattern stayed in IR pattern were classified into the stay in IR group. The median follow-up period was 17 months. The average age was 68 ± 11 years old, and 97 patients (63%) were male. Among 155 patients, 27 were classified into the change to PN group. A Cox proportional hazard analysis confirmed that the change in the peak atrial systolic TMF velocity during the LPP (ΔA, hazard ratio = 0.58 per 1SD; 95% CI = 0.39-0.88, P = 0.010) was the powerful independent predictor of change into PN pattern. Kaplan-Meier analysis revealed that the patients with ΔA -7 cm/s had more likely to develop into PN pattern than patients with ΔA > -7 cm/s (P = 0.001). Evaluation of a response in TMF during the LPP might provide an incremental diagnostic value to detect future overt heart failure in patients with early-stage heart failure. (Tokushima University Institutional Repository) ● Metadata: 112877 (Link to Publication Site) ● Publication site (DOI): 10.1111/echo.14098 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 30005132 ● Summary page in Scopus @ Elsevier: 2-s2.0-85054773574 (Tokushima University Institutional Repository: 112877, DOI: 10.1111/echo.14098, PubMed: 30005132, Elsevier: Scopus)
17.	Takeshi Soeki, Tomomi Matsuura, Takeshi Tobiume, Sachiko Bando, Matsumoto Kazuhisa, Hiromi Nagano, Etsuko Uematsu, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro and Masataka Sata : Clinical, Electrocardiographic, and Echocardiographic Parameter Combination Predicts the Onset of Atrial Fibrillation., Circulation Journal, Vol.82, No.9, 2253-2258, 2018. (Summary) The ability to identify risk markers for new-onset atrial fibrillation (AF) is critical to the development of preventive strategies, but it remains unknown whether a combination of clinical, electrocardiographic, and echocardiographic parameters predicts the onset of AF. In the present study, we evaluated the predictive value of a combined score that includes these parameters.Methods and Results:We retrospectively studied 1,040 patients without AF who underwent both echocardiography and 24-h Holter electrocardiography between May 2005 and December 2010. During a median follow-up period of 68.4 months (IQR, 49.9-93.3 months), we investigated the incidence of new-onset AF. Of the 1,040 patients, 103 (9.9%) developed AF. Patients who developed AF were older than patients who did not. Total heart beats, premature atrial contraction (PAC) count, maximum RR interval, and frequency of sinus pause quantified on 24-h electrocardiography were associated with new-onset AF. LA diameter (LAD) on echocardiography was also associated with the development of AF. On multivariate Cox analysis, age 58 years, PAC count 80 beats/day, maximum RR interval 1.64 s, and LAD 4.5 cm were independently associated with the development of AF. The incidence rate of new-onset AF significantly increased as the combined score (i.e., the sum of the risk score determined using hazard ratios) increased. A combined score that includes age, PAC count, maximum RR interval, and LAD could help characterize the risk of new-onset AF. (Tokushima University Institutional Repository) ● Metadata: 113221 (Link to Publication Site) ● Publication site (DOI): 10.1253/circj.CJ-17-0758 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 29848884 ● Summary page in Scopus @ Elsevier: 2-s2.0-85052204332 (Tokushima University Institutional Repository: 113221, DOI: 10.1253/circj.CJ-17-0758, PubMed: 29848884, Elsevier: Scopus)
18.	Gulinu Maimaituxun, Michio Shimabukuro, Daiju Fukuda, Shusuke Yagi, Yukina Hirata, Takashi Iwase, Shoichiro Takao, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masafumi Harada and Masataka Sata : Local Thickness of Epicardial Adipose Tissue Surrounding the Left Anterior Descending Artery Is a Simple Predictor of Coronary Artery Disease - New Prediction Model in Combination With Framingham Risk Score., Circulation Journal, Vol.82, No.5, 1369-1378, 2018. (Summary) Compared with global cardiac adiposity, the local accumulation of fat surrounding coronary arteries might have a more direct impact on coronary artery disease (CAD). Here, we compared the local epicardial adipose tissue (EAT) thickness and global cardiac adiposity volumes for predicting CAD.Methods and Results:A total of 197 consecutive subjects underwent 320-slice multi-detector computed tomography coronary angiography and were segregated into CAD (1 coronary artery branch stenosis 50%) and non-CAD groups. EAT thickness was measured at the right coronary artery (EAT), the left anterior descending artery (EAT), and the left circumflex artery (EAT). Although EATand EATwere similar between the 2 groups, EATwas larger in the CAD group than in the non-CAD group (5.45±2.16 mm vs. 6.86±2.19 mm, P<0.001). EAT, after correcting for confounding factors, was strongly associated with CAD (r=0.276, P<0.001) and Gensini score (r=0.239, P<0.001). On multiple regression analysis, Framingham risk score combined with EATwas a strong predictor of CAD (adjusted R=0.121; P<0.001). The local fat thickness surrounding the LAD is a simple and useful surrogate marker for estimating the presence, severity, and extent of CAD, independent of classical cardiovascular risk factors. (Tokushima University Institutional Repository) ● Metadata: 112879 (Link to Publication Site) ● Publication site (DOI): 10.1253/circj.CJ-17-1289 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 29563352 ● Summary page in Scopus @ Elsevier: 2-s2.0-85045965929 (Tokushima University Institutional Repository: 112879, DOI: 10.1253/circj.CJ-17-1289, PubMed: 29563352, Elsevier: Scopus)
19.	Hiromu Yamazaki, Shusuke Yagi, Yuta Torii, Rie Amano, Yasuyuki Oomichi, Teruaki Sangawa, Daiju Fukuda, Muneyuki Kadota, Takayuki Ise, Rie Ueno, Tomoya Hara, Kenya Kusunose, Tomomi Matsuura, Takeshi Tobiume, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masashi Akaike and Masataka Sata : Edoxaban improves acute venous thromboembolism while preserving protein C and protein S levels, Journal of Cardiology, Vol.71, No.3, 305-309, 2017. (Summary) It is well known that warfarin inhibits the synthesis of vitamin K-dependent anticoagulants, including thrombin, protein C and S, and factor Xa, leading, paradoxically, to an initial hypercoagulable state. Edoxaban, a direct inhibitor of activated factor X is widely used for the treatment of acute venous thromboembolism (VTE). However, the effect of edoxaban on circulating coagulation factors, in patients with acute VTE, remains unknown. We enrolled 57 patients with acute VTE with/without pulmonary embolism treated with edoxaban (n=37) or warfarin (n=20) in a clinical setting. Before treatment and 2 weeks after treatment, we evaluated thrombotic burden using ultrasound or computed tomography angiography. We also evaluated thrombin generation, represented by prothrombin fragment F1+2; thrombus degradation, represented by D-dimer; and levels of anticoagulants, including protein C, protein S, and antithrombin III. Both edoxaban and warfarin treatment improved thrombotic burden and decreased prothrombin fragment F1+2, and D-dimer. Edoxaban treatment preserved protein C and protein S levels. In contrast, warfarin decreased protein C and protein S levels. Neither treatment affected antithrombin III. Edoxaban improves VTE while preserving protein C and protein S levels, thereby indicating that edoxaban improves thrombotic burden while maintaining levels of anticoagulants. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jjcc.2017.09.009 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 29100817 ● Summary page in Scopus @ Elsevier: 2-s2.0-85032912457 (DOI: 10.1016/j.jjcc.2017.09.009, PubMed: 29100817, Elsevier: Scopus)
20.	Shusuke Yagi, Ken-ichi Aihara, Takeshi Kondo, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Daiju Fukuda, Yutaka Nakaya, Kin-Ichiro Suwaki, Takashi Takeji, Toshihiro Wada, Masdan Hotimah Salim, Saori Hama, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Takeshi Tobiume, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Munehide Matsuhisa, Michio Shimabukuro, Masashi Akaike and Masataka Sata : Predictors for the Treatment Effect of Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus., Advances in Therapy, Vol.35, No.1, 124-134, 2017. (Summary) Predictors for the effect of sodium glucose co-transporter 2 (SGLT2) inhibitors at lowering hemoglobin A1c (HbA1c) levels in type 2 diabetes mellitus patients remain unclear. We therefore aimed to elucidate these predictors in type 2 diabetes patients after 3 months of SGLT2 treatment. A total of 302 consecutive type 2 diabetes patients who had been treated with SGLT2 inhibitors as monotherapy or add-on therapy to existing antidiabetic treatments were enrolled retrospectively. After excluding 27 patients whose HbA1c levels could not be evaluated 3 months after treatment, the glucose-lowering effects of SGLT2 inhibitors were assessed in 275 patients by measuring HbA1c levels before and 3 months after treatment. The predictors for changes in HbA1c levels after 3 months of treatment were evaluated. SGLT2 inhibitor treatment for 3 months decreased HbA1c levels from 7.8 ± 1.2% to 7.4 ± 1.0% (p < 0.0001). A multiple regression analysis showed that the independent determinants for SGLT2 inhibitor treatment effect included decreased HbA1c levels after 1 month of treatment, high baseline HbA1c levels, and a high estimated glomerular filtration rate (eGFR). We show that type 2 diabetes patients who received the greatest glucose-lowering effect with SGLT2 inhibitor treatment were those with preserved renal function (high baseline eGFR) and high baseline HbA1c levels. Moreover, SGLT2 inhibitor treatment efficacy could be predicted by the patients' initial response to treatment. (Link to Publication Site) ● Publication site (DOI): 10.1007/s12325-017-0639-z (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 29185199 ● Summary page in Scopus @ Elsevier: 2-s2.0-85035102977 (DOI: 10.1007/s12325-017-0639-z, PubMed: 29185199, Elsevier: Scopus)
21.	Shusuke Yagi, Takeshi Soeki, Ken-Ichi Aihara, Daiju Fukuda, Takayuki Ise, Muneyuki Kadota, Sachiko Bando, Tomomi Matsuura, Takeshi Tobiume, Koji Yamaguchi, Kenya Kusunose, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro, Masashi Akaike and Masataka Sata : Low Serum Levels of Eicosapentaenoic Acid and Docosahexaenoic Acid are Risk Factors for Cardiogenic Syncope in Patients with Brugada Syndrome, International Heart Journal, Vol.58, No.5, 720-723, 2017. (Summary) The n-3 polyunsaturated fatty acids (PUFAs), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have antiarrhythmic effects, possibly via modulation of the cardiac ion channels. Nevertheless, it is unknown whether low serum levels of n-3 PUFAs are risk factors for ventricular fibrillation in patients with Brugada syndrome (BrS). We retrospectively reviewed data from 62 men with BrS and evaluated their serum levels of EPA and DHA, and the risk factors for sudden cardiac death, including a history of cardiogenic syncope. Nineteen patients had a history of cardiogenic syncope, and their EPA and DHA levels were significantly lower than those of the patients without syncope. Multivariate logistic regression analysis revealed that low EPA and DHA levels were associated with the incidence of syncope. The receiver-operator characteristic curve showed the area under the curves of EPA and DHA for history of syncope were 0.84 and 0.72, respectively. In conclusion, low levels of EPA and DHA are risk factors for cardiogenic syncope in patients with BrS, which suggests that n-3 PUFAs play important roles in preventing ventricular fibrillation in BrS. (Keyword) Adult / Aged / Aged, 80 and over / Biomarkers / Brugada Syndrome / Chromatography, Gas / Docosahexaenoic Acids / Eicosapentaenoic Acid / Electrocardiography / Follow-Up Studies / Humans / Incidence / Japan / Male / Middle Aged / Prevalence / ROC Curve / Retrospective Studies / Risk Assessment / Risk Factors / Syncope / Young Adult (Link to Publication Site) ● Publication site (DOI): 10.1536/ihj.16-278 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28966307 ● CiNii @ National Institute of Informatics (CRID): 1390282680202467328 ● Summary page in Scopus @ Elsevier: 2-s2.0-85032215381 (DOI: 10.1536/ihj.16-278, PubMed: 28966307, CiNii: 1390282680202467328, Elsevier: Scopus)
22.	Yuriko Takagawa, Shusuke Yagi, Takayuki Ise, Ayumi Ishii, Koji Nishikawa, Daiju Fukuda, Kenya Kusunose, Tomomi Matsuura, Takeshi Tobiume, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Michio Shimabukuro, Shinsuke Katoh, Ken-ichi Aihara, Masashi Akaike and Masataka Sata : Improved Exercise Capacity After Cardiac Rehabilitation Is Associated with Reduced Visceral Fat in Patients with Chronic Heart Failure., International Heart Journal, Vol.58, No.5, 746-751, 2017. (Summary) Participation in a comprehensive cardiac rehabilitation (CR) program has been shown to reduce mortality and improve exercise capacity and symptoms in patients with chronic heart failure (CHF). Reduced exercise capacity leads to a concomitant reduction of skeletal muscle mass and accumulation of body fat. However, it is currently unknown whether CR reduces visceral adipose tissue (VAT) and/or subcutaneous abdominal adipose tissue (SAT) in patients with CHF. In addition, the body composition associated with improved exercise capacity after CR in patients with CHF has not been previously studied. Nineteen CHF patients who were categorized as NYHA functional class II or III and had received optimal medical treatment including a CR program for 5 months were enrolled in this study. The CR program significantly increased peak VO and reduced B-type natriuretic peptide. In addition, fat and body composition analysis showed reductions in the visceral fat tissue (VAT) area, subcutaneous abdominal adipose tissue (SAT) area, body weight, and total fat weight after CR. There were no changes in total water weight and total muscle weight. Single regression analysis revealed that the amelioration of reduced exercise capacity seen after CR is associated with reduced VAT area but not with SAT area or body weight. In conclusion, CR reduces VAT and improves exercise capacity in patients with CHF. This suggests that reducing VAT is important for CR to be most effective in the treatment of CHF. (Keyword) Body Composition / Cardiac Rehabilitation / Exercise Tolerance / Female / Follow-Up Studies / heart failure / Humans / Intra-Abdominal Fat / Male / Middle Aged / obesity / oxygen consumption / Prognosis / Retrospective Studies / Weight Loss (Tokushima University Institutional Repository) ● Metadata: 110111 (Link to Publication Site) ● Publication site (DOI): 10.1536/ihj.16-454 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28966316 ● Summary page in Scopus @ Elsevier: 2-s2.0-85032221042 (Tokushima University Institutional Repository: 110111, DOI: 10.1536/ihj.16-454, PubMed: 28966316, Elsevier: Scopus)
23.	Shusuke Yagi, Yukina Hirata, Takayuki Ise, Kenya Kusunose, Hirotsugu Yamada, Daiju Fukuda, Salim Masdan Hotimah, G Maimaituxun, Susumu Nishio, Yuriko Takagawa, Saori Hama, Tomomi Matsuura, Koji Yamaguchi, Takeshi Tobiume, Takeshi Soeki, Tetsuzo Wakatsuki, Ken-ichi Aihara, Masashi Akaike, Michio Shimabukuro and Masataka Sata : Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus., Diabetology & Metabolic Syndrome, Vol.9, 78, 2017. (Summary) It is unknown whether canagliflozin, a selective sodium glucose co-transporter 2 inhibitor, reduces epicardial adipose tissue (EAT) thickness, which is associated with insulin resistance and is a risk factor for coronary artery disease. We administered 100 mg of canagliflozin for 6 months to 13 patients with type 2 diabetes mellitus. We evaluated glycemic control, visceral adipose tissue (VAT) area and subcutaneous adipose tissue (SAT) area, and skeletal muscle mass by using impedance methods, and EAT thickness by using echocardiography. Canagliflozin treatment for 6 months decreased hemoglobin A1c level from 7.1 ± 0.5% to 6.7 ± 0.6% (P < 0.05) and decreased EAT thickness from 9.3 ± 2.5 to 7.3 ± 2.0 mm (P < 0.001), along with a trend of decreasing VAT and SAT area. No association was found between any of these changes. Canagliflozin reduced EAT thickness in patients with type 2 diabetes mellitus independent of its effect on lowering blood glucose, suggesting that canagliflozin may have an effect in preventing cardiovascular events in these patients (UMIN000021327). (Tokushima University Institutional Repository) ● Metadata: 114544 (Link to Publication Site) ● Publication site (DOI): 10.1186/s13098-017-0275-4 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 29034006 ● Summary page in Scopus @ Elsevier: 2-s2.0-85030465923 (Tokushima University Institutional Repository: 114544, DOI: 10.1186/s13098-017-0275-4, PubMed: 29034006, Elsevier: Scopus)
24.	Maimaituxun Gulinu, Michio Shimabukuro, Hotimah Masdan Salim, Minoru Tabata, Daisuke Yuji, Yoshihisa Morimoto, Takeshi Akasaka, Tomomi Matsuura, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Takaki Sugimoto, Masashi Tanaka, Shuichiro Takanashi and Masataka Sata : Gender-linked impact of epicardial adipose tissue volume in patients who underwent coronary artery bypass graft surgery or non-coronary valve surgery, PLoS ONE, Vol.12, No.6, e0177170, 2017. (Summary) Traditional and non-traditional risk factors for atherosclerotic cardiovascular disease (ASCVD) are different between men and women. Gender-linked impact of epicardial adipose tissue volume (EATV) in patients undergoing coronary artery bypass grafting (CABG) remains unknown. Gender-linked impact of EATV, abdominal fat distribution and other traditional ASCVD risk factors were compared in 172 patients (men: 115; women: 57) who underwent CABG or non-coronary valvular surgery (non-CABG). In men, EATV, EATV index (EATV/body surface area) and the markers of adiposity such as body mass index, waist circumference and visceral fat area were higher in the CABG group than in the non-CABG group. Traditional ASCVD risk factors were also prevalent in the CABG group. In women, EATV and EATV index were higher in the CABG group, but other adiposity markers were comparable between CABG and non-CABG groups. Multivariate logistic regression analysis showed that in men, CABG was determined by EATV Index and other ASCVD risk factors including hypertension, dyslipidemia, adiponectin, high sensitive C-reactive protein (hsCRP) and type 2 diabetes mellitus (Corrected R2 = 0.262, p < 0.0001), while in women, type 2 diabetes mellitus is a single strong predictor for CABG, excluding EATV Index (Corrected R2 = 0.266, p = 0.005). Our study found that multiple risk factors, including epicardial adipose tissue volume and traditional ASCVD factors are determinants for CABG in men, but type 2 diabetes mellitus was the sole determinant in women. Gender-specific disparities in risk factors of CABG prompt us to evaluate new diagnostic and treatment strategies and to seek underlying mechanisms. (Tokushima University Institutional Repository) ● Metadata: 112321 (Link to Publication Site) ● Publication site (DOI): 10.1371/journal.pone.0177170 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28594865 ● Summary page in Scopus @ Elsevier: 2-s2.0-85020391442 (Tokushima University Institutional Repository: 112321, DOI: 10.1371/journal.pone.0177170, PubMed: 28594865, Elsevier: Scopus)
25.	S Bando, Takeshi Soeki, Tomomi Matsuura, Takeshi Tobiume, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Takashi Iwase, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro, Naoki Muguruma, Tetsuji Takayama, I Kishimoto, Kenji Kangawa and Masataka Sata : Plasma brain natriuretic peptide levels are elevated in patients with cancer, PLoS ONE, Vol.12, No.6, e0178607, 2017. (Summary) Natriuretic peptides have been proposed as biomarkers of cardiovascular disease, especially heart failure. Brain natriuretic peptide (BNP) has also been shown to be upregulated at the transcriptional and translational levels by pro-inflammatory cytokines in cardiac myocytes. Although we often measure plasma BNP levels in cancer patients, it remains unknown whether cancer-related inflammation affects the plasma BNP levels. We investigated the relationship between the BNP and human cancers. We retrospectively studied 2,923 patients in whom the plasma BNP levels and serum C-reactive protein (CRP) were measured and echocardiography was performed. Patients with clinically evident heart failure (NYHA II or higher), heart disease requiring medical treatment or surgery, renal dysfunction, and inflammatory disease were excluded. There were 234 patients in the final analysis. Blood sampling was performed before surgery and chemotherapy. In addition, we evaluated the relationship between the inflammation and plasma BNP levels in mouse models of colon cancer. Of the 234 patients, 80 were diagnosed with cancer. Both the plasma BNP and serum CRP levels were significantly higher in cancer patients than those without. There were no significant differences in the echocardiographic parameters. There was a significant positive correlation between the plasma BNP and serum CRP levels in cancer patients (r = 0.360, P<0.01) but not in those without. In cancer patients, only the CRP correlated with the BNP independent of the age, creatinine level, hypertension, and body mass index. In addition, in nude mice with subcutaneous colon cancer, the plasma BNP level was elevated compared with that in non-cancer mice, and there was a significant relationship between the plasma BNP and serum levels of the inflammatory markers. In cancer patients, as well as colon cancer model mice, the plasma BNP levels were elevated, possibly due to cancer-related inflammation. The effect of cancer on the BNP levels should be considered when using BNP as an indicator of heart failure in cancer patients. (Tokushima University Institutional Repository) ● Metadata: 112318 (Link to Publication Site) ● Publication site (DOI): 10.1371/journal.pone.0178607 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28570595 ● Search Scopus @ Elsevier (PMID): 28570595 ● Search Scopus @ Elsevier (DOI): 10.1371/journal.pone.0178607 (Tokushima University Institutional Repository: 112318, DOI: 10.1371/journal.pone.0178607, PubMed: 28570595)
26.	M Kadota, Takayuki Ise, Shusuke Yagi, Takashi Iwase, Masashi Akaike, R Ueno, Y Kawabata, T Hara, K Ogasawara, Mika Bando, S Bando, Tomomi Matsuura, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : Response prediction and influence of tolvaptan in chronic heart failure patients considering the interaction of the renin-angiotensin-aldosterone system and arginine vasopressin., International Heart Journal, Vol.57, No.4, 461-465, 2016. (Summary) The renin-angiotensin-aldosterone system (RAAS) and arginine vasopressin (AVP) regulate body fluids. Although conventional diuretics have been used for treating heart failure, they activate RAAS and exacerbate renal function. Tolvaptan, a newly developed vasopressin-2 receptor antagonist, elicits aquaresis and improves volume overload in heart failure patients, however, the predictors of tolvaptan effectiveness and the influence on the RAAS and renal function according to tolvaptan therapy are not established. We evaluated 26 chronic heart failure patients receiving therapy with 15 mg/day tolvaptan and examined their laboratory and urinary data before and after tolvaptan therapy. A response to tolvaptan was defined as a body weight decrease by more than 2 kg in a week and a urine volume increase by 500 mL/ day compared with that before tolvaptan administration. Body weight, urine volume, and brain natriuretic peptide levels significantly improved (P < 0.05), without any worsening of renal function represented by serum creatinine, sodium, and potassium. Moreover, no significant changes were observed in the plasma renin activity and plasma aldosterone concentration (PAC). In the responder group, urine osmolality before tolvaptan administration was significantly higher (P < 0.05) but declined significantly after tolvaptan administration (P < 0.05). The AVP/PAC ratio before administration was positively correlated with the efficacy of tolvaptan. Tolvaptan treatment could prevent RAAS activation in chronic heart failure patients. Moreover, monitoring the AVP/PAC ratio may be useful in predicting the tolvaptan response. (Keyword) Adult / Aged / Aged, 80 and over / Antidiuretic Hormone Receptor Antagonists / Arginine Vasopressin / Benzazepines / Body Mass Index / Female / Heart Failure / Humans / Male / Middle Aged / Prospective Studies / Renin-Angiotensin System / Treatment Outcome (Tokushima University Institutional Repository) ● Metadata: 109694 (Link to Publication Site) ● Publication site (DOI): 10.1536/ihj.15-491 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27357439 ● Summary page in Scopus @ Elsevier: 2-s2.0-84979587993 (Tokushima University Institutional Repository: 109694, DOI: 10.1536/ihj.15-491, PubMed: 27357439, Elsevier: Scopus)
27.	Takeshi Soeki, Tomomi Matsuura, Sachiko Bando, Takeshi Tobiume, Etsuko Uematsu, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro and Masataka Sata : Relationship between local production of microRNA-328 and atrial substrate remodeling in atrial fibrillation., Journal of Cardiology, Vol.68, No.6, 472-477, 2016. (Summary) BACKGROUND: The underlying mechanism of atrial substrate remodeling in atrial fibrillation (AF) remains unknown. In this study, we investigated whether local and systemic levels of microRNA (miR) might be associated with the presence of AF and with left atrial (LA) substrate properties.METHODS: Blood from the periphery, pulmonary vein (PV), and left atrial appendage (LAA) was sampled from 30 patients with AF undergoing PV isolation, and from 10 control subjects with Wolff-Parkinson-White syndrome and without AF. We measured peripheral, PV, and LAA plasma levels of miR-1, -26, -133a, -328, and -590 by reverse transcription-polymerase chain reaction. LA global contact mapping during sinus rhythm was performed before PV isolation.RESULTS: Plasma levels of miR-328 were higher in patients with AF than in control subjects. Plasma miR-328 levels were significantly higher in the LAA than in the periphery and PV in patients with AF, but not in control subjects. Plasma miR-1 levels were also higher in the LAA than in the PV in AF patients. Interestingly, LAA plasma levels of miR-328 showed a positive correlation with the LA voltage zone index (area with voltage <0.5mV divided by total LA surface area) and a weak correlation with LA volume.CONCLUSION: Local production of miR-328 in the left atrium may be involved in the process of atrial remodeling in patients with AF. (Keyword) Atrial fibrillation / Left atrium / MicroRNA / Remodeling / Substrate (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jjcc.2015.12.007 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 26987792 ● Summary page in Scopus @ Elsevier: 2-s2.0-84960969355 (DOI: 10.1016/j.jjcc.2015.12.007, PubMed: 26987792, Elsevier: Scopus)
28.	S Bando, Daiju Fukuda, Takeshi Soeki, S Nishimoto, E Uematsu, Tomomi Matsuura, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro and Masataka Sata : Expression of NLRP3 in subcutaneous adipose tissue is associated with coronary atherosclerosis., Atherosclerosis, Vol.242, No.2, 407-414, 2015. (Summary) ObjectivesThe promotion of adipose tissue inflammation by lifestyle-related diseases such as obesity and diabetes accelerates atherogenesis; however, the underlying mechanisms remain incompletely understood. Nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3) inflammasome contributes to chronic inflammation in adipose tissue. Here, we investigated the link between NLRP3 expression in subcutaneous adipose tissue (SAT) and the severity of coronary atherosclerosis.Methods and resultsSAT was obtained from 72 patients who underwent heart device implantation and coronary angiography. Expression of NLRP3 inflammasome-related molecules (NLRP3, IL-1 and IL-18) in SAT were evaluated by quantitative RT-PCR. Laboratory markers related to lifestyle-related diseases were measured. Patients with obesity, dyslipidemia (P < 0.05, respectively), diabetes or hyperuricemia (P < 0.01, respectively) had significantly higher expression of NLRP3. Multivariate analysis demonstrated that body mass index and serum level of uric acid were predictors of NLRP3 expression in SAT. The expression of NLRP3 in SAT correlated negatively with serum adiponectin level (r = 0.23, P < 0.05). Patients with coronary artery disease showed higher NLRP3 expression than patients without significant stenosis (P < 0.01). Furthermore, the expression of NLRP3 in SAT correlated positively with the severity of coronary atherosclerosis as determined by Gensini score (r = 0.47, P < 0.0001) or SYNTAX score (r = 0.55, P < 0.0001). Multiple regression analysis revealed that the expression of NLRP3 in SAT remains as an independent predictors for the severity of coronary atherosclerosis.ConclusionsThe expression of NLRP3 in SAT, which is affected by lifestyle-related diseases, is associated with the severity of coronary atherosclerosis. Our results suggest that NLRP3 inflammasome in SAT may have a role in atherogenesis. (Keyword) Atherosclerosis / Adipose tissue / Inflammation / NLRP3 inflammasome / Lifestyle-related disease (Tokushima University Institutional Repository) ● Metadata: 109532 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.atherosclerosis.2015.07.043 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 26282945 ● Search Scopus @ Elsevier (PMID): 26282945 ● Search Scopus @ Elsevier (DOI): 10.1016/j.atherosclerosis.2015.07.043 (Tokushima University Institutional Repository: 109532, DOI: 10.1016/j.atherosclerosis.2015.07.043, PubMed: 26282945)
29.	Shusuke Yagi, Ken-ichi Aihara, Masashi Akaike, Daiju Fukuda, HM Salim, Masayoshi Ishida, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Michio Shimabukuro, Toshio Matsumoto and Masataka Sata : Predictive factors for efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus., Diabetes & Metabolism Journal, Vol.39, No.4, 342-347, 2015. (Summary) BACKGROUND: Predictive factors for the efficacy of dipeptidyl peptidase-4 (DPP-4) inhibitors for lowering glycosylated hemoglobin (HbA1c) remain unclear in patients with type 2 diabetes mellitus. The aim of this study is therefore to clarify predictive factors of the efficacy of DPP-4 inhibitors for lowering HbA1c after 12 months of treatment.METHODS: A total of 191 consecutive type 2 diabetic patients (male sex 55%, mean age, 68.3±35.8 years), who had been treated with DPP-4 inhibitors for 12 months, were enrolled in this study and evaluated retrospectively.RESULTS: After 12 months of DPP-4 inhibitor treatment, random blood glucose level, and HbA1c level, decreased from 167±63 to 151±49 mg/dL (P<0.01), and from 7.5%±1.3% to 6.9%±0.9% (P<0.01) respectively, without severe side effects. Multiple regression analysis showed that predictors of DPP-4 inhibitor treatment efficacy in lowering HbA1c level after 12 months were a decrease in HbA1c level after 3 months of treatment, a high baseline HbA1c level, a low baseline body mass index, and the absence of coronary artery disease.CONCLUSION: Most suitable candidates for treatment with DPP-4 inhibitors are diabetics who are not obese and do not have coronary artery disease. In addition, long-term efficacy of DPP-4 inhibitors can be predicted by decrement of HbA1c after 3 months of treatment. (Keyword) Coronary artery disease / diabetes mellitus / Dipeptidyl-peptidase IV inhibitors / Obese / Predictive factors (Link to Publication Site) ● Publication site (DOI): 10.4093/dmj.2015.39.4.342 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 26301197 ● Summary page in Scopus @ Elsevier: 2-s2.0-84939780057 (DOI: 10.4093/dmj.2015.39.4.342, PubMed: 26301197, Elsevier: Scopus)

Proceeding of International Conference:

1.	Kohei Nagano, Tomonori Takahashi, Tetsuzo Wakatsuki, Robert Zheng, Yoshihito Saijyo, Muneyuki Kadota, Yutaka Kawabata, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Long-Term Outcome of Stentless Coronary Intervention With Drug-Coated Balloon in Patients With High Bleeding Risk, AHA2023, Philadelphia, Nov. 2023.
2.	Ryou Bando, Tetsuzo Wakatsuki, Koji Yamaguchi, Yutaka Kawabata, Tomonori Takahashi, Yoshihito Saijyo, Muneyuki Kadota, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, S Yagi, Hirotsugu Yamada, T Soeki, M Akaike and Masataka Sata : Two-year outcomes of drug-coated balloon only strategy for de novo lesions in large coronary vessels, ESC2023, Amsterdam, Aug. 2023.
3.	Koji Yamaguchi, Tetsuzo Wakatsuki, Y Okushi, Kumiko Suto, Kazuhisa Matsumoto, Tomonori Takahashi, Muneyuki Kadota, Yutaka Kawabata, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Early and chronic phased local coagulative responses following bioresorbable-polymer drug-eluting stent implantation, European Heart Journal, Vol.42, No.S1, ehab724.1245, Aug. 2021. (Link to Publication Site) ● Publication site (DOI): 10.1093/eurheartj/ehab724.1245 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.1093/eurheartj/ehab724.1245 (DOI: 10.1093/eurheartj/ehab724.1245)
4.	Koji Yamaguchi, Tetsuzo Wakatsuki, Tomonori Takahashi, Muneyuki Kadota, Yutaka Kawabata, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Suppressed Local Coagulative Response After Newer-generation Ultrathin Strut SES Implantation Compared to Older-generation SES Implantation, American Heart Association, Dallas, Nov. 2020. (Link to Publication Site) ● Publication site (DOI): 10.1161/circ.142.suppl_3.12894 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.1161/circ.142.suppl_3.12894 (DOI: 10.1161/circ.142.suppl_3.12894)
5.	Takeshi Soeki, Kazuhisa Matsumoto, Daiju Fukuda, E Uematsu, Tomomi Matsuura, Takeshi Tobiume, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : Toll-like receptor 9 is a novel therapeutic target to prevent atrial fibrillation, European Heart Journal, Vol.41, No.S2, ehaa946.0463, Aug. 2020. (Link to Publication Site) ● Publication site (DOI): 10.1093/ehjci/ehaa946.0463 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.1093/ehjci/ehaa946.0463 (DOI: 10.1093/ehjci/ehaa946.0463)
6.	Takeshi Soeki, Kazuhisa Matsumoto, Daiju Fukuda, 植松悦子, Tomomi Matsuura, Takeshi Tobiume, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : Vildagliptin reduces inducitiligy of arterial fibrillation in hypertensive rats complicated with diabetes mellitus, ESC Congress 2019, Paris, Sep. 2019.
7.	Koji Yamaguchi, Tetsuzo Wakatsuki, Rie Ueno, Yutaka Kawabata, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : The improvement of chronic local coagulative response according to the progress of drug eluting stent, ESC Congress 2019, Paris, Sep. 2019.
8.	Takeshi Soeki, E Uematsu, Tomomi Matsuura, Takeshi Tobiume, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : C-type natriuretic peptide improves left ventricular diastolic dysfunction and ischemia/reperfusion injury-associated ventricular arrhythmias., ESC2018, Munich, Aug. 2018.
9.	Hiroyuki Ito, Tetsuzo Wakatsuki, Koji Yamaguchi, Daiju Fukuda, Yutaka Kawabata, Takafumi Todoroki, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Growth of vasa vasorum is associated with local inflammation around coronary plaque in fresh cadavers, ESC2018, Munich, Aug. 2018.
10.	Maimaituxun Gulinu, Michio Shimabukuro, Daiju Fukuda, Shusuke Yagi, Hirata Yukina, Takashi Iwase, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : Gender disparities of distribution of epicardial adipose tissue and its impact on coronary artery disease, ESC2018, Munich, Aug. 2018.
11.	Takeshi Soeki, Tomomi Matsuura, E Uematsu, Takeshi Tobiume, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : Epicardial Adipose Tissue Produces Proinflammatory Cytokines and Influences the Pathogenesis of Atrial Fibrillation, AHA Scientific Sessions2017, California, America, Nov. 2017.
12.	Maimaituxun. Gulinu, Michio Shimabukuro, Y Hirata, Takashi Iwase, S Takao, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, M Harada and Masataka Sata : Local Epicardial Adipose Tissue Thickness in Left Anterior Descending Artery Provides a New Prediction Model for Coronary Artery Disease, AHA Scientific Sessions2017, California, America, Nov. 2017.
13.	Takeshi Soeki, Tomomi Matsuura, Daiju Fukuda, Etsuko Uematsu, Takeshi Tobiume, T Hara, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : Activated Factor X Signaling Pathway via Protease-Activated Receptor-2 is a Novel Therapeutic Target to Prevent Atrial Fibrillation, AHA Scientific Sessions2017, California, America, Nov. 2017.
14.	Koji Yamaguchi, Tetsuzo Wakatsuki, Yutaka Kawabata, H Ito, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Preserved Endothelial Function and Suppressed Local Coagulative and Inflammatory Response After Biodegradable Polymer SES Implantation Compared to Durable Polymer SES, AHA Scientific Sessions2017, California, America, Nov. 2017.
15.	Tomomi Matsuura, Takeshi Tobiume, Takeshi Soeki, R Kato, M Hara, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : Direct Slow Pathway Capture: A New Electrophysiological Method of Catheter Ablation for Atrioventricular Nodal Reentrant Tachycardia, AHA Scientific Sessions2017, California, America, Nov. 2017.
16.	Takeshi Soeki, Tomomi Matsuura, E Uematsu, S Bando, Takeshi Tobiume, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro and Masataka Sata : Increased local production of C-type natriuretic peptide in patients with vasospastic angina, ESC Congress 2016, Rome, Aug. 2016.
17.	Koji Yamaguchi, Tetsuzo Wakatsuki, R Ueno, H Ito, Takayuki Ise, Tomomi Matsuura, Kenya Kusunose, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Paclitaxel eluting balloon angioplasty equals everolimus eluting stent implantation in local coagulative and inflammatory responses in stable angina patients, ESC Congress 2016, Rome, Aug. 2016.
18.	S Bando, Takeshi Soeki, Tomomi Matsuura, Takeshi Tobiume, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : Atrial Late Potentials and Atrial Substrate Remodeling in Patients With Atrial Fibrillation., AHA Scientific Sessions 2015, Orlando, Nov. 2015.
19.	Takeshi Soeki, S Bando, Tomomi Matsuura, Takeshi Tobiume, E Uematsu, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro and Masataka Sata : Combination Of Clinical, Electrocardiographic and Echocardiographic Parameters Predict the Onset of Atrial Fibrillation., AHA Scientific Sessions 2015, Orlando, Nov. 2015.
20.	Koji Yamaguchi, Tetsuzo Wakatsuki, A Takashima, Mika Bando, S Bando, Tomomi Matsuura, Takayuki Ise, Junko Hotsuchi, Takeshi Tobiume, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Differential response of local coagulation after implantation of new generation drug-eluting stents compared with sirolimus-eluting stent., AHA Scientific Sessions 2014, Chicago, Nov. 2014.
21.	H Yamazaki, Tetsuzo Wakatsuki, Koji Yamaguchi, K Imada, K Matsumoto, Y Takagawa, E Takagi, Y Saijo, T Hara, Y Saito, Mika Bando, A Takashima, S Bando, Tomomi Matsuura, Takayuki Ise, Junko Hotsuchi, Takeshi Tobiume, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Differential responses of local coagulation after implantation of second-generation drug-eluting stent compared with first-generation drug-eluting stents., AHA Scientific Sessions 2014, Chicago, Nov. 2014.
22.	Tomomi Matsuura, Takeshi Soeki, E Uematsu, S Bando, Takeshi Tobiume, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro and Masataka Sata : A renin inhibitor prevents atrial endocardial dysfunction in rapidly paced rats with streptozotocin-induced diabetes., ESC 2014, Barcelona, Aug. 2014.
23.	Takeshi Soeki, E Uematsu, S Bando, Tomomi Matsuura, Takeshi Tobiume, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro and Masataka Sata : Relationship between local production of microRNA-328 and atrial substrate remodeling in atrial fibrillation., ESC 2014, Barcelona, Aug. 2014.
24.	S Bando, Takeshi Soeki, Takeshi Tobiume, Tomomi Matsuura, E Uematsu, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro and Masataka Sata : Atrial late potentials and atrial substrate remodeling in patients with atrial fibrillation., ESC 2014, Barcelona, Aug. 2014.

Proceeding of Domestic Conference:

1.	BOLLOS CHRISTINE ANNE LEAH LOCSIN, Ryosuke Kasai, Hideki Otsuka, Youichi Otomi, Tomomi Matsuura, Tamaki Otani, BANDOH Takanori, UEKI Yuya, MATSUDA Noritake, 高志智, Shota Azane, Yamato Kunikane, Shoichiro Takao, Shusuke Yagi, Masataka Sata, Hitoshi Ikushima and Masafumi Harada : Ventilation/Perfusion Mismatch in Pulmonary Vein Stenosis After Atrial Fibrillation Ablation, 第268回徳島医学会学術集会, Mar. 2024.
2.	R Bando, Koji Yamaguchi, Tetsuzo Wakatsuki, Yutaka Kawabata, Tomonori Takahashi, H Orino, I Yagi, Tomoko Takahashi, Zheng Robert, Yoshihito Saijyo, Tomoya Hara, Muneyuki Kadota, Tomomi Matsuura, Takayuki Ise, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Predictors of Late Lumen Enlargement after Drug Coated Balloon Angioplasty for de Novo Coronary Lesions, 第88回日本循環器学会学術集会, Mar. 2024.
3.	Yutaka Kawabata, Koji Yamaguchi, Tetsuzo Wakatsuki, Tomonori Takahashi, Ryo Bando, Yoshihito Saijyo, 門田宗之, Tomomi Matsuura, Takayuki Ise, Shusuke Yagi, Takeshi Soeki and Masataka Sata : Microvasculature and Gene Expression in Pericoronary Adipose Tissue According to Coronary Plaque Progression Stage in Fresh Cadavers, 第88回日本循環器学会学術集会, Mar. 2024.
4.	Yoshihito Saijyo, Hirotsugu Yamada, 長野絋平, 折野逸人, 八木一成, TAKAHASHI Tomoko, Zengu Robahto, BANDO Ryo, Tomonori Takahashi, Tomoya Hara, Muneyuki Kadota, Yutaka Kawabata, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : Incremental Value of Relative Apical Sparing Index for Discrimination of Cardiac Amyloidosis Subtypes, 第88回日本循環器学会学術集会, Mar. 2024.
5.	Ryo Bando, Koji Yamaguchi, Tetsuzo Wakatsuki, Yutaka Kawabata, Tomonori Takahashi, Hayato Orino, Issei Yagi, Tomonori Takahashi, Zheng Robert, Yoshihito Saijyo, Tomoya Hara, Muneyuki Kadota, Tomomi Matsuura, Takayuki Ise, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Predictors of Late Lumen Enlargement after Drug Coated Balloon Angioplasty for de Novo Coronary Lesions, 第88回日本循環器学会学術集会 JCS2024, Mar. 2024.
6.	Yutaka Kawabata, Koji Yamaguchi, Tetsuzo Wakatsuki, Tomonori Takahashi, BANDO Ryo, Yoshihito Saijyo, Muneyuki Kadota, Tomomi Matsuura, Takayuki Ise, Shusuke Yagi, Takeshi Soeki and Masataka Sata : Microvasculature and Gene Expression in Pericoronary Adipose Tissue According to Coronary Plaque Progression Stage in Fresh Cadavers, 第88回日本循環器学会学術集会, Mar. 2024.
7.	Yoshihito Saijyo, Hirotsugu Yamada, 長野絋平, 折野逸人, 八木一成, TAKAHASHI Tomoko, Zengu Robahto, BANDO Ryo, Tomonori Takahashi, Tomoya Hara, Muneyuki Kadota, Yutaka Kawabata, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : Incremental Value of Relative Apical Sparing Index for Discrimination of Cardiac Amyloidosis Subtypes, 第88回日本循環器学会学術集会, Mar. 2024.
8.	八木一成, Yoshihito Saijyo, 長野絋平, 折野逸人, Naofumi Yoshida, TAKAHASHI Tomoko, Zengu Robahto, BANDO Ryo, Tomonori Takahashi, Tomoya Hara, Muneyuki Kadota, Yutaka Kawabata, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : ALおよびATTR心アミロイドーシス間のエコー図検査的特徴の相違に関する検討, 第123回日本循環器学会四国支部地方会, Dec. 2023.
9.	八木一成, Yoshihito Saijyo, 長野絋平, 折野逸人, Naofumi Yoshida, TAKAHASHI Tomoko, Zengu Robahto, BANDO Ryo, Tomonori Takahashi, Tomoya Hara, Muneyuki Kadota, Yutaka Kawabata, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : ALおよびATTR心アミロイドーシス間のエコー図検査的特徴の相違に関する検討, 第123回日本循環器学会四国支部地方会, Oct. 2023.
10.	Zengu Robahto, Muneyuki Kadota, Keita Ohtani, Hayato Orino, Yusuke Negishi, Tomoko Takahashi, Ryo Bando, Hiromitsu Seno, Tomonori Takahashi, Yoshihito Saijyo, Yutaka Kawabata, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : A Case of Biopsy-Proven Giant Cell Myocarditis, 第37回日本心エコー図学会学術集会, Apr. 2023.
11.	BANDO Ryo, Tetsuzo Wakatsuki, Koji Yamaguchi, Yutaka Kawabata, Ryota Miyamoto, Zengu Robahto, Tomonori Takahashi, Yoshihito Saijyo, Rie Ueno, Muneyuki Kadota, Tomoya Hara, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Masashi Akaike and Masataka Sata : Two-year Outcomes of Drug-coated Balloon-only Strategy for De Novo Lesions in Large Coronary Vessels, 第87回日本循環器学会学術集会, Mar. 2023.
12.	Yoshihito Saijyo, Yuichiro Okushi, Kenya Kusunose, Hirotsugu Yamada, Zengu Robahto, Tomonori Takahashi, Hiromitsu Seno, Susumu Nishio, Rie Ueno, Muneyuki Kadota, Tomoya Hara, Yutaka Kawabata, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : Utility of Periodic Echocardiographic Surveillance for Early Detection of Cardiac Dysfunction from Chemotherapy in Breast Cancer Patients, 第87回日本循環器学会学術集会, Mar. 2023.
13.	Yutaka Kawabata, Tetsuzo Wakatsuki, Koji Yamaguchi, BANDO Ryo, Yoshihito Saijyo, Rie Ueno, Muneyuki Kadota, Tomoya Hara, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : The Impact of Coronary Plaque Progression Stage on Coronary Neovascularization Structures in Fresh Cadavers, 第87回日本循環器学会学術集会, Mar. 2023.
14.	Takayuki Ise, Shusuke Yagi, Rie Ueno, Muneyuki Kadota, Keita Ohtani, Yusuke Negishi, Ryota Miyamoto, BANDO Ryo, Zengu Robahto, Hiromitsu Seno, Tomonori Takahashi, Yutaka Kawabata, Yoshihito Saijyo, Tomomi Matsuura, Kenya Kusunose, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : Novel Home-based Cardiac Telerehabilitation System Using a Wearable Device and a Web Application, 第87回日本循環器学会学術集会, Mar. 2023.
15.	吉田知哉, Takayuki Ise, 宮本亮太, BANDO Ryo, Zengu Robahto, Hiromitsu Seno, Tomonori Takahashi, Yutaka Kawabata, Tomomi Matsuura, Yoshihito Saijyo, Muneyuki Kadota, Kenya Kusunose, Takeshi Soeki, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki, 飯間努, 山本浩史 and Masataka Sata : 劇症型心筋炎に対してECPELLA導入で救命しえた症例, 第121回日本循環器学会四国地方会, Dec. 2022.
16.	Tomonori Takahashi, Kenya Kusunose, Zheng Robert, Seno Hiromitsu, Yoshihito Saijyo, Muneyuki Kadota, Yutaka Kawabata, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 心房細動患者におけるイソプロテレノール負荷経食堂心エコー図法の有用性, 第121回日本循環器学会四国地方, Dec. 2022.
17.	松崎慶仁, Yoshihito Saijyo, Takayuki Ise, 太田啓太, 折野逸人, 吉田知哉, 根岸佑典, 宮本亮太, 坂東遼, Rovert Zheng, Hiromitsu Seno, Tomonori Takahashi, Rie Ueno, Muneyuki Kadota, Tomoya Hara, Yutaka Kawabata, Tomomi Matsuura, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 急性A型大動脈解離をきたしたMarfan症候群の一例, 第265回徳島県医学学術集会, Jul. 2022.
18.	Yusuke Negishi, Muneyuki Kadota, Koji Yamaguchi, Hirotsugu Yamada, 折野逸人, 太田啓太, 吉田知哉, 宮本亮太, BANDO Ryo, Zheng Rovert, Hiromitsu Seno, Tomonori Takahashi, Yoshihito Saijyo, Rie Ueno, Tomoya Hara, Yutaka Kawabata, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki, 田蒔昌憲 and Masataka Sata : 腎動脈拡張術により心不全の著名な改善を認めたCardiac Disturbance syndrome の1例, 第265回徳島県医学学術集会, Jul. 2022.
19.	Shusuke Yagi, Takayuki Ise, Muneyuki Kadota, Yutaka Kawabata, Tomoya Hara, Rie Ueno, Yoshihito Saijyo, Tomomi Matsuura, Kenya Kusunose, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : パンデミック下の臨床実習におけるオンライン医学教育の実際と問題点, 第265回徳島県医学学術集会, Jun. 2022.
20.	林昌晃, Takeshi Soeki, 玉上大暉, 野田康裕, 森西啓介, 近田優介, Kazuhisa Matsumoto, Tomomi Matsuura, 大西芳明 and Masataka Sata : 心房細動アズレーション時の鎮静不安定化に寄与する因子の検討, 第68回日本不整脈心電学会学術大会, Jun. 2022.
21.	Rikako Takahashi, Muneyuki Kadota, Takayuki Ise, Yoshihito Saijyo, Yutaka Kawabata, Tomomi Matsuura, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 免疫抑制療法の導入により心機能が劇的に改善した巨細胞性心筋炎の一例, 第120回日本循環器学会中国・四国合同地方会, May 2022.
22.	Muneyuki Kadota, Kenya Kusunose, Shusuke Yagi, Yutaka Kawabata, Yoshihito Saijyo, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 慢性心不全におけるサクビトリル / バルサルタンのナトリウム利尿ペプチドに対する急性反応の検討, 第120回日本循環器学会中国・四国合同地方会, May 2022.
23.	Yutaka Kawabata, Tetsuzo Wakatsuki, Koji Yamaguchi, Daiju Fukuda, Yoshihito Saijyo, Muneyuki Kadota, Tomomi Matsuura, 伊勢孝之, Kenya Kusunose, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : First Assessment of Coronary Plaque Vulnerability and Lipid Core Burden Assessed by Near-Infrared Spectroscopy-Intravascular Ultrasound in a Fresh Cadaver, 第86回日本循環器学会学術集会, Mar. 2022.
24.	Tomonori Takahasi, Kenya Kusunose, Yukina Hirata, Susumu Nisio, Yuichiro Okushi, Hiromitsu Seno, Y Saijo, Muneyuki Kadota, Yutaka Kawabata, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : Cardiovascular Risk Factors Associated with Left Ventricular Strain Distribution in Patients without Known Cardiovascular Disease, 第86回日本循環器学会学術集会, Mar. 2022.
25.	Yoshihito Saijyo, Takaaki Samura, Tomoko Takahashi, Yuichiroh Ohkushi, Hiromitsu Seno, 高橋智紀, Muneyuki Kadota, Yutaka Kawabata, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Hiroki Hata and Masataka Sata : 滲出性収縮性心膜炎の1例, 第119回日本循環器学会四国地方会, Dec. 2021.
26.	Yutaka Kawabata, Tetsuzo Wakatsuki, Koji Yamaguchi, Muneyuki Kadota, Takayuki Ise, Kenya Kusunose, Tomomi Matsuura, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : 冠動脈塞栓症を発症した2症例の臨床的検討, 第69回日本心臓病学会学術集会, Sep. 2021.
27.	Rei Mizobuchi, Hironori Tanaka, Naoya Tani, Kazuyoshi Noda, Takahiro Tanaka, Tetsu Tomonari, Tatsuya Taniguchi, Tomomi Matsuura, Masataka Sata and Tetsuji Takayama : 超音波観察を併用することで安全に治療した高度腎機能低下を合併した猪瀬型肝性脳症の1例, 第263回徳島医学会学術集会, Aug. 2021.
28.	Tomoya Yoshida, Hiromitsu Seno, Kazuhisa Matsumoto, Tomomi Matsuura, Yoshihito Saijyo, Muneyuki Kadota, Yutaka Kawabata, Kenya Kusunose, Takayuki Ise, Takeshi Soeki, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki, 多田恵曜 and Masataka Sata : ペースメーカー植え込み後に発覚した側頭葉てんかんによる発作性心静止の一例, 第263回徳島医学会学術集会, Aug. 2021.
29.	M Tserensonom, Shusuke Yagi, Takayuki Ise, Muneyuki Kadota, Yutaka Kawabata, Yoshihito Saijyo, Tomomi Matsuura, Kenya Kusunose, Koji Yamaguchi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 動脈硬化性疾患の高リスク患者において大動脈弁の石灰化と血清リポ蛋白との関連, 第263回徳島医学会学術集会, Aug. 2021.
30.	Kazuki Tezuka, Tomonori Takahashi, Yoshihito Saijyo, Yutaka Kawabata, Muneyuki Kadota, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Takaaki Samura, Hiroki Hata and Masataka Sata : ポスタ-セッション左冠動脈主幹部の急性冠症候群の2症例, 第263回徳島医学会学術集会(令和3年度夏期), Aug. 2021.
31.	Takeshi Soeki, Daiju Fukuda, Tomomi Matsuura, Takeshi Tobiume, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : Toll-Like Receptor 9 Is a Novel Therapeutic Target to Prevent Atrial Fibrillation, JHRS2021 第67回日本不整脈心電学会学術大会, Jul. 2021.
32.	Tomomi Matsuura, Takeshi Soeki, Kazuhisa Matsumoto, Takeshi Tobiume and Masataka Sata : Efficacy and Clinical Significance of Additional Left Atrial Posterior Wall Isolation in Patients with Persistent Atrial Fibrillation, 第67回日本不整脈心電学会学術大会, Jul. 2021.
33.	Akihiro Tani, Shusuke Yagi, Muneyuki Kadota, Yutaka Kawabata, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : 肺動脈性肺高血圧症に対する静注プロスタグランジン投与で高心拍出を呈した症例, 第116回第118回日本循環器学会中国・四国合同地方会, Jun. 2021.
34.	Hiromitsu Seno, Kazuhisa Matsumoto, Tomomi Matsuura, Takeshi Tobiume, Takeshi Soeki, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : ペースメーカー植込み後にj発覚した側頭葉てんかんによる発作性心静止の1例, 第124回日本内科学会四国地方会, May 2021.
35.	Koji Yamaguchi, Tetsuzo Wakatsuki, Yuichiroh Ohkushi, Kumiko Suto, 松本和久, Tomonori Takahashi, Muneyuki Kadota, Yutaka Kawabata, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Early and Chronic Phased Local Coagulative Responses Following Bioresorbable-polymer Drug-eluting Stent Implantation, 第85回日本循環器学会学術集会, Mar. 2021.
36.	Yutaka Kawabata, Tetsuzo Wakatsuki, Koji Yamaguchi, Daiju Fukuda, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, 添木武 and Masataka Sata : Relationship between Coronary Intraplaque Microluminal Structure and Epicardial Adipose Tissue and Plaque Formation -A Fresh Cadaveric Study-, 第85回日本循環器学会学術集会, Mar. 2021.
37.	Yutaka Kawabata, Tetsuzo Wakatsuki, Koji Yamaguchi, Daiju Fukuda, Hiroyuki Ito, Takayuki Ise, Kenya Kusunose, Tomomi Matsuura, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : 光干渉断層法で観察される冠動脈壁微小管腔構造と局所冠動脈周囲脂肪内炎症および冠動脈プラークの関連 -未固定遺体における検討-, Beyond Angiography Japan XXV, Mar. 2021.
38.	Takuya Yamada, Akihiro Tani, Muneyuki Kadota, Takayuki Ise, Yutaka Kawabata, Tomomi Matsuura, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 大動脈四尖弁に対してTAVIを施行した一症例, 第262回徳島医師学会学術集会, Mar. 2021.
39.	ムギー (名), Shusuke Yagi, Muneyuki Kadota, Yutaka Kawabata, 松本和久, Kenya Kusunose, Koji Yamaguchi, Takeshi Tobiume, Tomomi Matsuura, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 当院におけるイバブラジンの使用経験, 第262回徳島医師学会学術集会, Mar. 2021.
40.	Muneyuki Kadota, Shusuke Yagi, Takayuki Ise, Yutaka Kawabata, Tomomi Matsuura, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : Acute Hormonal Effect of the Angiotensin Receptor-Neprilysin Inhibitor in Patients with Chronic Heart Failure, 第85回日本循環器学会学術集会, Mar. 2021.
41.	Kazuhisa Matsumoto, Takeshi Tobiume, Tomomi Matsuura, Takeshi Soeki and Masataka Sata : 断端処理後リードの先端露出に対して鎖骨骨膜固定法が有用であった1例, 第12回植込みデバイス関連冬季大会, Feb. 2020.
42.	髙橋智子, Kazuhisa Matsumoto, Tomomi Matsuura, Takeshi Tobiume, Takeshi Soeki and Masataka Sata : S-ICDにpolytetrafluoroethyleneを被覆したこと，肥満により胸骨リードの挿入が浅くなったことでshock impedanceが著名に上昇した1例, 第12回植込みデバイス関連冬季大会, Feb. 2020.
43.	青井優, Kozo Kagawa, Nobuhito Naito, Seidai Satou, Hiroshi Kawano, Jinsei Miyoshi, Tomomi Matsuura, Hideya Kashihara, Kouzou Yoshikawa, Yuko Toyoda, Yoshimi Bando, Hiroshi Nokihara, Tetsuji Takayama, Mitsuo Shimada and Yasuhiko Nishioka : 好酸球性多発血管炎性肉芽腫症の治療中に回腸出血をきたし，血管炎との鑑別が困難であったCMV腸炎の1例, 第260回徳島医学会学術集会, Feb. 2020.
44.	Kazuhisa Matsumoto, Yutaka Kawabata, Tomomi Matsuura, Takeshi Tobiume, Takeshi Soeki and Hirotsugu Yamada : リードレスペースメーカーの再挿入を要したアミロイドーシスの一例, 第115回日本循環器学会四国地方会, Dec. 2019.
45.	Muneyuki Kadota, Kenya Kusunose, Takayuki Ise, Tomonori Takahashi, 藤本裕太, Yuichiroh Ohkushi, Kumiko Sutou, Kazuhisa Matsumoto, 上野理絵, Yutaka Kawabata, nao Yamada, Tomomi Matsuura, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : ドブダミン負荷下での血行動態評価を行った潜在性閉塞性肥大型心筋症2症例の検討, 第115回日本循環器学会四国地方会, Dec. 2019.
46.	Koji Yamaguchi, Tetsuzo Wakatsuki, Kazuhisa Matsumoto, Tomonori Takahashi, 上野理絵, Yutaka Kawabata, Tomomi Matsuura, Kenya Kusunose, Takeshi Tobiume, Takayuki Ise, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : クライオバルーンアブレーション後の肺静脈狭窄に対するDrug coated balloonの使用経験, 第115回日本循環器学会四国地方会, Dec. 2019.
47.	Koji Yamaguchi, Tetsuzo Wakatsuki, Kazuhisa Matsumoto, Tomonori Takahashi, 上野理絵, Yutaka Kawabata, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : 新規病変に対するDrug coated balloonの効果―局所血管反応と臨床成績について―, 第115回日本循環器学会四国地方会, Dec. 2019.
48.	Takeshi Tobiume, Tomomi Matsuura, Kazuhisa Matsumoto, Sachiko Bandoh, 大河啓介, Takeshi Soeki and Masataka Sata : 房室ブロックの予防に順行性速伝導路と順行性遅伝導路のマッピングが有用であった順行性速伝導路の下方偏位を伴う遅速型房室結節リエントリー性頻拍の1 例, カテーテルアブレーション関連秋季大会2019, Nov. 2019.
49.	林昌晃, Takeshi Soeki, 玉上大暉, 野田康裕, 森西啓介, Kazuhisa Matsumoto, Sachiko Bandoh, Tomomi Matsuura, Takeshi Tobiume, Yoshiaki Ohnishi and Masataka Sata : 心房細動アブレーション時の鎮静不安定化に影響を及ぼす背景因子の検討, カテーテルアブレーション関連秋季大会2019, Nov. 2019.
50.	髙橋智子, Tomomi Matsuura, Kazuhisa Matsumoto, Sachiko Bandoh, Takeshi Tobiume, Koji Yamaguchi, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : クライオバルーンアブレーション後にきたした高度肺静脈狭窄に対してDrugcoated balloon を用いて治療を行った1 例, カテーテルアブレーション関連秋季大会2019, Nov. 2019.
51.	Kazuhisa Matsumoto, Takeshi Tobiume, Sachiko Bandoh, Tomomi Matsuura, Takeshi Soeki and Masataka Sata : Crista terminalis を横断する伝導によりpseudo conduction を呈し，同部位への通電でcomplete isthmus block を確認し得た心房粗動の1 例, カテーテルアブレーション関連秋季大会2019, Nov. 2019.
52.	木田貴弘, Takeshi Tobiume, 松本和久, 坂東左知子, Tomomi Matsuura, Takeshi Soeki, 志村拓哉, 髙橋智子, 谷彰浩, 藤本裕太, 大櫛祐一郎, 數藤久美子, 髙橋智紀, 上野理絵, 門田宗之, 川端豊, Mika Bando, 山田なお, Hiroyuki Ito, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : 房室ブロックの進行に伴い明らかになり，恒久的ペースメーカー植込み術後のファーフィールドR波センシングへの関与が疑われた束枝心室間副伝導路の1例, 第259回徳島医学会学術集会, Aug. 2019.
53.	井口裕貴, Takeshi Tobiume, 松本和久, 坂東左知子, Tomomi Matsuura, Takeshi Soeki, 志村拓哉, 髙橋智子, 谷彰浩, 藤本裕太, 大櫛祐一郎, 數藤久美子, 髙橋智紀, 上野理絵, 門田宗之, 川端豊, Mika Bando, 山田なお, Hiroyuki Ito, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : 房室ブロックの予防に順行性速伝導路と順行性遅伝導路のマッピングが有用であった順行性速伝導路の下方偏位を伴う遅速型房室結節リエントリー性頻拍の1例, 第259回徳島医学会学術集会, Aug. 2019.
54.	Kazuhisa Matsumoto, Takeshi Soeki, Tomomi Matsuura, Takeshi Tobiume and Masataka Sata : Vidagliptin reduces inducibility of atrial fibrillation in hypertensive rats complicated with diabetes mellitus, 第66回日本不整脈心電学会学術大会, Jul. 2019.
55.	Gulinu Maimaituxun, Daiju Fukuda, Shusuke Yagi, Yukina Hirata, Takashi Iwase, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata and Michio Shimabukuro : Gender specific impact of epicardial adipose tissue thickness on coronary artery disease, 第19回日本抗加齢医学会総会, Jun. 2019.
56.	Takeshi Soeki, Daiju Fukuda, Tomomi Matsuura, 植松悦子 and Masataka Sata : 抗凝固薬の新しい可能性, 第4回J-ISCP(国際心血管薬物療法学会日本部会)年次学術集会会長企画セッション―心血管薬物治療の新たな可能性―, Jun. 2019.
57.	數藤久美子, Kenya Kusunose, Tomomi Matsuura, 山田なお, 松本和久, 上野理絵, 川端豊, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 進行性心不全を呈す抗ミトコンドリア抗体陽性筋炎の症例, 第114回日本循環器学会中国・四国合同地方会, Jun. 2019.
58.	谷彰浩, Kenya Kusunose, 松本和久, Tomomi Matsuura, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masashi Akaike and Masataka Sata : 拡張期僧帽弁逆流の治療適応判断に心房心室同時ペーシングが有効であった1例, 第114回日本循環器学会中国・四国合同地方会, Jun. 2019.
59.	志村拓哉, Takayuki Ise, 川端豊, 藤本裕太, 松本和久, 上野理絵, 山田なお, Hiroyuki Ito, Tomomi Matsuura, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Hirotsugu Kurobe, Eiki Fujimoto and Masataka Sata : 先天性二尖弁に対するTAVIの2例, 第114回日本循環器学会中国・四国合同地方会, Jun. 2019.
60.	大池由夏, Takeshi Tobiume, 松本和久, 山田なお, 坂東左知子, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Tetsuzo Wakatsuki, Takeshi Soeki, Hirotsugu Yamada and Masataka Sata : His束より上方レベルの心房刺激でのみ誘発可能であった房室結節リエントリー性頻拍の1例, 第114回日本循環器学会中国・四国合同地方会, Jun. 2019.
61.	松本和久, Tomomi Matsuura, Takeshi Tobiume, Takeshi Soeki and Masataka Sata : 心臓電気生理検査中に4種類の頻拍が出現し治療に難渋した一例, 第114回日本循環器学会中国・四国合同地方会, Jun. 2019.
62.	平田有紀奈, Kenya Kusunose, Kumiko Kagawa, 山口夏美, 森田沙瑛, 鳥居裕太, 山尾雅美, 西尾進, 山田なお, Tomomi Matsuura, 阿部美保, Hirotsugu Yamada and Masataka Sata : 悪性リンパ腫の診断および経過観察に心エコー図検査が有用であった1例, 第114回日本循環器学会中国・四国合同地方会, Jun. 2019.
63.	Gulinu Maimaituxun, Daiju Fukuda, Shusuke Yagi, Yukina Hirata, T Iwase, S Takao, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masafumi Harada, Masataka Sata and Michio Shimabukuro : Kidney fat and its impact on coronary artery disease, 第4回日本血管不全学会学術集会・総会, Apr. 2019.
64.	Gulinu Maimaituxun, Daiju Fukuda, Shusuke Yagi, Yukina Hirata, T Iwase, S Takao, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masafumi Harada, Masataka Sata and Michio Shimabukuro : Peri-renal fat volume is negatively associated with the adiponectin expression in human, 第4回日本血管不全学会学術集会・総会, Apr. 2019.
65.	Hiroyuki Ito, Tetsuzo Wakatsuki, Koji Yamaguchi, Daiju Fukuda, 川端豊, 轟貴史, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Microluminal structures of coronary plaque and vasa vasorums affect coronary inflammation: A fresh cadaveric studys, 第83回日本循環器学会学術集会, Mar. 2019.
66.	Takeshi Soeki, Tomomi Matsuura, Daiju Fukuda, 松本和久, Takeshi Tobiume, Kenya Kusunose, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : The Factor Xa Inhibitor, Edoxaban, Prevents Cardiac Remodeling in Rats with Myocardial Infarction, 第83回日本循環器学会学術集会, Mar. 2019.
67.	川端豊, Tetsuzo Wakatsuki, Koji Yamaguchi, Hiroyuki Ito, Daiju Fukuda, 轟貴史, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Coronary intraplaque microluminal structure are associated with the quality and quantity of epicardial adipose tissue -A fresh cadaveric stury-, 第83回日本循環器学会学術集会, Mar. 2019.
68.	Zheng Robert, Takayuki Ise, 川端豊, Shusuke Yagi, 西條良仁, 上野理絵, Mika Bando, Hiroyuki Ito, 轟貴史, Tomomi Matsuura, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Hirotsugu Kurobe, Eiki Fujimoto, Tetsuya Kitagawa and Masataka Sata : Single coronary 合併重症ASに対してTAVIを施行し救命し得た1例, 第113回日本循環器学会四国合同地方会, Dec. 2018.
69.	Yutaka Kawabata, Tetsuzo Wakatsuki, Koji Yamaguchi, Hiroyuki Itou, Kenya Kusunose, Tomomi Matsuura, Takafumi Todoroki, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : 未固定遺体において光干渉断層法で観察される冠動脈壁微小管腔構造と局所周囲脂肪炎症との関連, 第66回日本心臓病学会学術集会, Sep. 2018.
70.	Hiroyuki Ito, Tetsuzo Wakatsuki, Koji Yamaguchi, Daiju Fukuda, Yutaka Kawabata, Takayuki Ise, Kenya Kusunose, Tomomi Matsuura, Takafumi Todoroki, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : 未固定遺体における冠動脈壁小管腔構造と局所心臓周囲脂肪内炎症との関連, 第66回日本心臓病学会学術集会, Sep. 2018.
71.	Koji Yamaguchi, Tetsuzo Wakatsuki, Yoshihito Saijoh, 上野理絵, Yutaka Kawabata, Mika Bando, Hiroyuki Ito, Takafumi Todoroki, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : 第三世代薬剤溶出性ステント留置後における局所凝固反応塗装ステント長の関連性, 第66回日本心臓病学会学術集会, Sep. 2018.
72.	Hiroyuki Ito, Takeshi Soeki, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : AVNRTアブレーション治療後に発生したJunctional Tachycardiaの1例, 第112回日本循環器学会中国・四国合同地方会, Jun. 2018.
73.	Takafumi Todoroki, Tetsuzo Wakatsuki, Koji Yamaguchi, Seno Hiromitsu, Kumiko Sutou, Yoshihito Saijoh, Yutaka Kawabata, 上野理絵, Hiroyuki Ito, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, Takeshi Tobiume, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : EES留置3年後，術前に抗血小板剤中止しペパリン置換したにもかかわらず2枝同時ステント閉塞を起こした1例, 第112回日本循環器学会中国・四国合同地方会, Jun. 2018.
74.	Zheng Robert, Kumiko Sutou, Kenya Kusunose, Tomomi Matsuura, Hiromitsu Seno, Yoshihito Saijoh, 上野理絵, Yutaka Kawabata, Mika Bando, ito hironori, Takafumi Todoroki, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 薬物治療が著効したSLE関連心筋炎の一例, 第112回日本循環器学会中国・四国合同地方会, Jun. 2018.
75.	Yoshihito Saijoh, Kenya Kusunose, Hirotsugu Yamada, Susumu Nishio, Hiromitsu Seno, Kumiko Sutou, Yutaka Kawabata, 上野理絵, Hiroyuki Itou, Takafumi Todoroki, Tomomi Matsuura, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : アトラサイクリン系抗癌剤による心筋障害の局在性および化学療法関連心筋障害との関連の検討, 第112回日本循環器学会中国・四国合同地方会, Jun. 2018.
76.	Yoshihito Saijoh, Kenya Kusunose, Hirotsugu Yamada, Susumu Nishio, Yukina Hirata, Yuta Torii, Kumiko Sutou, 上野理絵, Yutaka Kawabata, Hiroyuki Itou, Takafumi Todoroki, Tomomi Matsuura, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : Anthracyclines induce early changes in localized left ventricular dysfunction., 第82回日本循環器学会, Mar. 2018.
77.	Takeshi Soeki, Tomomi Matsuura, Daiju Fukuda, Takeshi Tobiume, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : C-type natriuretic peptide improves left ventricular diastolic dysfunction in HFpEF model rats., 第82回日本循環器学会, Mar. 2018.
78.	Yutaka Kawabata, Takeshi Soeki, Takayuki Ise, Tomomi Matsuura, Yoshihito Saijoh, Takeshi Tobiume, Shusuke Yagi, Koji Yamaguchi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : Effects of L-/N-type Calcium Channel Blocker on Proteinuria and Angiotensin -renin Feedback in Hypertensive Patients, 第82回日本循環器学会, Mar. 2018.
79.	Takayuki Ise, Shusuke Yagi, Yutaka Kawabata, Seno Hiromitsu, Kumiko Sutou, Yoshihito Saijoh, Rie Ueno, Hiroyuki Ito, Takafumi Todoroki, Tomomi Matsuura, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : Acute Hemodynamic Effect of Handgrip Stress in Patients with Chronic Heart Failure., 第82回日本循環器学会, Mar. 2018.
80.	Yukina Hirata, Kenya Kusunose, Hirotsugu Yamada, Yuta Torii, Susumu Nishio, Hiromitsu Seno, Tomomi Matsuura, Koji Yamaguchi, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : Impact of Marathon Running on Left Atrial function in healthy trained volunteers, 第82回日本循環器学会, Mar. 2018.
81.	Koji Yamaguchi, Tetsuzo Wakatsuki, Yutaka Kawabata, Hiroyuki Itou, Takafumi Todoroki, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Differential Response of Local Coagulation after Coronary Angioplasty with Paclitaxel., 第82回日本循環器学会, Mar. 2018.
82.	Tetsuzo Wakatsuki, Koji Yamaguchi, Daiju Fukuda, Yutaka Kawabata, 轟貴史, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Growth of vasa vasorum is associated with local inflammation around coronary plaque in fresh cadavers., 第82回日本循環器学会, Mar. 2018.
83.	Hiroyuki Ito, Tetsuzo Wakatsuki, Koji Yamaguchi, Daiju Fukuda, Yutaka Kawabata, 轟貴史, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Growth of Vasa Vasorum is Associated with Local Inflammation around Coronary Plaque in Fresh Cadavers(和訳中), 日本循環器学会学術集会抄録集, PJ007-3, Mar. 2018.
84.	Koji Yamaguchi, Tetsuzo Wakatsuki, Yutaka Kawabata, Hiroyuki Ito, 轟貴史, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Differential Response of Local Coagulation after Coronary Angioplasty with Paclitaxel(和訳中), 日本循環器学会学術集会抄録集, PJ022-1, Mar. 2018.
85.	Yutaka Kawabata, Takeshi Soeki, Takayuki Ise, Tomomi Matsuura, Kenya Kusunose, Takeshi Tobiume, Shusuke Yagi, Koji Yamaguchi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : Effects of L-/N-type Calcium Channel Blocker on Proteinuria and Angiotensin II-renin Feedback in Hypertensive Patients(和訳中), 日本循環器学会学術集会抄録集, PJ067-4, Mar. 2018.
86.	Gulinu Maimaituxun, Michio Shimabukuro, Daiju Fukuda, Shusuke Yagi, Yukina Hirata, Takashi Iwase, Shoichiro Takao, Tomomi Matsuura, Takayuki Ise, Tetsuzo Wakatsuki, Masafumi Harada and Masataka Sata : The impact of epicardial adipose tissue thickness on left ventricular diastolic dysfunction in patients with preserved ejection fraction, 日本老年医学会四国地方会, Feb. 2018.
87.	志村拓哉, 西條良仁, Koji Yamaguchi, Kenya Kusunose, Hirotsugu Yamada, 瀬野弘光, 數藤久美子, 上野理絵, 川端豊, 伊藤浩敬, 轟貴史, Tomomi Matsuura, Takayuki Ise, Takeshi Tobiume, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 下肢静脈血栓症の誘因となる下肢血流障害の検討-下肢静脈造影での検討-, 第111回日本循環器学会四国地方会, Dec. 2017.
88.	豊田直人, 轟貴史, Takeshi Soeki, 瀬野弘光, 數藤久美子, 西條良仁, 上野理絵, 川端豊, 伊藤浩敬, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Daiju Fukuda, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : 診断から40年後に治療しえた著明なBroad Kent束を有するWPW症候群の一例, 第111回日本循環器学会四国地方会, Dec. 2017.
89.	中野睦基, 川端豊, Takeshi Soeki, Tomomi Matsuura, Takeshi Tobiume, 瀬野弘光, 數藤久美子, 西條良仁, 上野理絵, 伊藤浩敬, 轟貴史, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : 嚥下性失神に対して高級性ペースメーカー植え込み術が有効であった1例, 第111回日本循環器学会四国地方会, Dec. 2017.
90.	矢野哲弘, Tomomi Matsuura, 數藤久美子, 瀬野弘光, 西條良仁, 上野理絵, 川端豊, 伊藤浩敬, 轟貴史, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 心房細動アブレーション後の医原性心房中隔欠損残存により右心不全症状をきたした一例, 第111回日本循環器学会四国地方会, Dec. 2017.
91.	Yutaka Kawabata, Tetsuzo Wakatsuki, Koji Yamaguchi, Hiroyuki Itou, Daiju Fukuda, Takayuki Ise, Kenya Kusunose, Tomomi Matsuura, 轟貴史, Akira Hirono, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : 未固定遺体における管脈プラーク性状と局所周囲脂肪内炎症物質との関連, 第65回日本心臓病学会学術集会, Sep. 2017.
92.	Koji Yamaguchi, Tetsuzo Wakatsuki, 川端豊, 伊藤浩敬, 轟貴史, Tomomi Matsuura, Kenya Kusunose, Takeshi Tobiume, Takayuki Ise, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Biodegradable polymer SESの慢性期局所血管反応の検討-Durable polymer SESとの比較-, 第65回日本心臓病学会学術集会, Sep. 2017.
93.	Yoshihito Saijoh, Kenya Kusunose, Hirotsugu Yamada, Seno Hiromitsu, Susumu Nishio, Hiroyuki Itou, Takafumi Todoroki, Takayuki Ise, Tomomi Matsuura, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Tetsuzo Wakatsuki and Masataka Sata : 経食道心エコー図検査の再検によりvegetationを同定しえた感染性心内膜炎の一例, 第65回日本心臓病学会学術集会, Sep. 2017.
94.	Takafumi Todoroki, Shusuke Yagi, Kenya Kusunose, Takayuki Ise, Yoshihito Saijoh, Seno Hiromitsu, Akira Hirono, Tomomi Matsuura, Daiju Fukuda, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masashi Akaike and Masataka Sata : 膠原病患者での肺動脈楔入圧と左室拡張期末期圧の関係, 第65回日本心臓病学会学術集会, Sep. 2017.
95.	荒瀬美晴, Takeshi Tobiume, Hiroyuki Itou, Tomomi Matsuura, Takeshi Soeki, Hiromitsu Seno, Yoshihito Saijoh, Yutaka Kawabata, 轟貴史, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : 薬物療法の継続が困難で頻脈誘発性心筋症を生じたが，カテーテルアブレーションにて合併症なく根治に成功した洞房リエントリー性頻拍の1例, 第255回徳島医学会学術集会, Aug. 2017.
96.	瀬野弘光, Takeshi Soeki, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : 計算負荷試験で誘発された心室性期外収縮の一例, 第110回日本循環器学会中国・四国合同地方会, Jun. 2017.
97.	Hiroyuki Itou, Takeshi Tobiume, Takeshi Soeki, Yuichiroh Ohkushi, Hiromitsu Seno, Yoshihito Saijoh, Yutaka Kawabata, 轟貴史, Akira Hirono, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : 左鎖骨下への植え込み型除細動器植え替え後に生じたTwiddler症候群の1例, 第110回日本循環器学会中国・四国合同地方会, Jun. 2017.
98.	川端豊, Takayuki Ise, Koji Yamaguchi, Tetsuzo Wakatsuki, Kenya Kusunose, Tomomi Matsuura, Shusuke Yagi, Takeshi Tobiume, Hirotsugu Yamada, Takeshi Soeki, 川谷洋平, 荒瀬裕己, Hirotsugu Kurobe, Eiki Fujimoto, Tetsuya Kitagawa and Masataka Sata : 肺癌術前にバルーン大動脈弁形成術を施行し良好な開大が得られた重症大動脈弁狭窄症の一例, 第110回日本循環器学会中国・四国地方会, Jun. 2017.
99.	Yoshihito Saijoh, Hirotsugu Yamada, Kenya Kusunose, Susumu Nishio, Yuichiroh Ohkushi, Hiromitsu Seno, Tomoya Hara, Yutaka Kawabata, Hiroyuki Itou, 轟貴史, Akira Hirono, Tomomi Matsuura, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki, Hirotsugu Kurobe, Shunsuke Watanabe and Masataka Sata : 著名な心内膜肥厚を認めた acromegalic cardiomyopathy の一例, 第110回日本循環器学会中国・四国地方会, Jun. 2017.
100.	西條良仁, Hirotsugu Yamada, Kenya Kusunose, 西尾進, 瀬野弘光, 大櫛祐一郎, 高木恵理, 上野理絵, 原知也, 川端豊, 斎藤友子, 伊藤浩敬, 轟貴史, Tomomi Matsuura, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : Impact of Left Atrial Ischemia on Left Atrial Reservoir Function in Patients with Old Myocardial Infarction, 第81回日本循環器学会学術集会, Mar. 2017.
101.	轟貴史, Shusuke Yagi, Kenya Kusunose, Hirotsugu Yamada, Takayuki Ise, Tomomi Matsuura, Takeshi Tobiume, Takeshi Soeki, Tetsuzo Wakatsuki, Masashi Akaike and Masataka Sata : Serum Level of Lipoprotein (a) is a Risk Factor for Aortic Valve Sclerosis in Women, 第81回日本循環器学会学術集会, Mar. 2017.
102.	大櫛祐一郎, Hirotsugu Yamada, Kenya Kusunose, 西條良仁, 瀬野弘光, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : Accuracy of Diagnosis of Elevated Left Atrial Pressure Using Recommendation for the Evaluation of Left Ventricular Diastolic Function by Echocardiograph, 第81回日本循環器学会学術集会, Mar. 2017.
103.	Takayuki Ise, Shusuke Yagi, 瀬野弘光, 西條良仁, 高木恵理, 上野理絵, 原知也, 伊藤浩敬, Tomomi Matsuura, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : Nocturnal Hypoxemia Predicts Cardiac Events in Patients with Cardiac Risk Factors, 第81回日本循環器学会学術集会, Mar. 2017.
104.	Maimaituxun Gulinu, Michio Shimabukuro, Koji Yamaguchi, Shusuke Yagi, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : Local Epicardial Adipose Tissue Thickness and Its Impact on Coronary Atherosclerosis, 第81回日本循環器学会学術集会, Mar. 2017.
105.	伊藤浩敬, Tetsuzo Wakatsuki, Koji Yamaguchi, Daiju Fukuda, 川端豊, 轟貴史, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Lipid-rich Coronary Plaque is Associated with Local Inflammation in Adjacent Epicardial Adipose Tissue in Fresh Cadaveric Models, 第81回日本循環器学会学術集会, Mar. 2017.
106.	Tetsuzo Wakatsuki, Koji Yamaguchi, 伊藤浩敬, Daiju Fukuda, 川端豊, 轟貴史, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : The Tissue Characteristics of Coronary Plaque with Microluminal Structures Identified by OCT Associated with Local Inflammatory Response in Fresh Cadavers, 第81回日本循環器学会学術集会, Mar. 2017.
107.	Koji Yamaguchi, Tetsuzo Wakatsuki, 伊藤浩敬, 川端豊, 轟貴史, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Comparison of Local Coagulative Response after Coronary Angioplasty - First Generation DES vs Second Generation-DES vs Drug Coated Balloon -, 第81回日本循環器学会学術集会, Mar. 2017.
108.	谷口実佑, Takeshi Soeki, Tomomi Matsuura, 佐藤裕紀, Takeshi Tobiume, 原知也, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro and Masataka Sata : Activated Factor X Signaling Pathway via Protease-Activated Receptor-2 is a Novel Therapeutic Target to Prevent Atrial Fibrillation, 第81回日本循環器学会学術集会, Mar. 2017.
109.	西山美月, Takeshi Tobiume, Tomomi Matsuura, Takeshi Soeki and Masataka Sata : 左鎖骨下への植込み型除細動器植え替え後に生じたTwiddler症候群の1例, 第254回徳島医学会学術集会, Feb. 2017.
110.	山本清成, 轟貴史, 大櫛祐一郎, 上野理恵, Takayuki Ise, 瀬野弘光, 西條良仁, 高木恵理, 原知也, 川端豊, 斎藤友子, 伊藤浩敬, Tomomi Matsuura, Takeshi Tobiume, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masashi Akaike, Masataka Sata, 門田友里, Masato Nishimura and Minoru Irahara : PET/CTにて診断できた心サルコイドーシスの1例, 第254回徳島医学会学術集会, Feb. 2017.
111.	Maimaituxun Gulinu, Michio Shimabukuro, Daiju Fukuda, Shusuke Yagi, Yukina Hirata, Takashi Iwase, Shoichiro Takao, Tomomi Matsuura, Takayuki Ise, Tetsuzo Wakatsuki, Masafumi Harada and Masataka Sata : The impact of epicardial adipose tissue thickness on left ventricular diastolic dysfunction in patients with preserved ejection fraction., Feb. 2017.
112.	Maimaituxun Gulinu, Michio Shimabukuro, 平田有紀奈, Takashi Iwase, Shoichiro Takao, Tomomi Matsuura, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, 田端実, 森本喜久, 赤坂武, 田中正史, 高梨秀一郎 and Masataka Sata : 心臓バイパス手術症例におけるリスク要因の定量的解析:古典的および非古典的リスクの性差, 脳心血管抗加齢研究会2016, Dec. 2016.
113.	Gulinu Maimaituxun, Michio Shimabukuro, 平田有紀奈, Takashi Iwase, 高尾正一郎, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, 原田雅史 and Masataka Sata : 局所心臓周囲脂肪厚の臨床的意義:冠動脈疾患での検討, 脳心血管抗加齢研究会2016, Dec. 2016.
114.	鈴木聖也, Hirotsugu Yamada, 高木恵理, 高川由利子, Tomomi Matsuura, Takayuki Ise, 平田有紀奈, Kenya Kusunose, 西條良仁, 瀬野弘光, 大櫛祐一郎, 西尾進, 山尾雅美, 鳥居裕太, Shusuke Yagi, Koji Yamaguchi, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 経食道心エコー検査により原因が究明された高齢発症の右心不全の1例, 第109回日本循環器学会四国地方会, Dec. 2016.
115.	上田浩之, 瀬野弘光, Tomomi Matsuura, Kenya Kusunose, Koji Yamaguchi, Hirotsugu Yamada, Tetsuzo Wakatsuki, Takeshi Soeki, 東島潤 and Masataka Sata : Bevacizumab併用化学療法中に深部静脈血栓症および肺塞栓症を発症した1例, 第109回日本循環器学会四国地方会, Dec. 2016.
116.	ロバートゼング, 西條良仁, Kenya Kusunose, Hirotsugu Yamada, 轟貴史, 西尾進, 瀬野弘光, 高木恵理, 上野理絵, 原知也, 川端豊, 齋藤友子, 伊藤浩敬, Tomomi Matsuura, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 左上肢脱力を主訴に来院されたが心エコー図法を契機に急性冠症候群と診断しえた一例, 第109回日本循環器学会四国地方会, Dec. 2016.
117.	本間友佳子, Yasunobu Hayabuchi, 小野朱美, Shoji Kagami, 井上美紀, Kazuhiro Mori, Masataka Sata, Takeshi Soeki, Takeshi Tobiume and Tomomi Matsuura : Left venous valve由来部位の異常自動能が示唆された右房後中隔起源の心房頻拍・頻拍誘発性心筋症の1女児例, 第21回日本小児心電学会学術集会, Nov. 2016.
118.	Tomomi Matsuura, Takeshi Soeki, Takeshi Tobiume and Masataka Sata : 右房低位中隔部に電気的不連続性を認めた通常型心房粗動の1例, カテーテルアブレーション関連秋季大会2016, Oct. 2016.
119.	Shusuke Yagi, Takayuki Ise, 西川幸治, 石井亜由美, Kenya Kusunose, Koji Yamaguchi, Tomomi Matsuura, Takeshi Tobiume, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masashi Akaike and Masataka Sata : 心不全患者に対するAdaptive servo-ventilation装着下6分間歩行における運動耐容能改善効果, 第64回日本心臓病学会学術集会, Sep. 2016.
120.	鈴川理乃, Hirotsugu Yamada, Kenya Kusunose, 西條良仁, 瀬野弘光, 衣川尚知, 平田有紀奈, 天野里江, 鳥居裕太, 山尾雅美, 西尾進, Tomomi Matsuura, Takeshi Tobiume, Takeshi Soeki and Masataka Sata : 持続性心房細動の肺静脈隔離術後における左房機能の回復と再発との関連, 第64回日本心臓病学会学術集会, Sep. 2016.
121.	Takeshi Soeki, 高橋甲介, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro and Masataka Sata : 心筋虚血再灌流障害に対する新たな治療薬としてのC型ナトリウム利尿ペプチドの可能性, 第64回日本心臓病学会学術集会, Sep. 2016.
122.	山上圭, 西條良仁, Kenya Kusunose, Hirotsugu Yamada, 瀬野弘光, 原知也, 上野理絵, 門田宗之, 齋藤友子, 山﨑宙, 坂東左知子, 伊藤浩敬, 轟貴史, Tomomi Matsuura, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 生体腎移植後における腎静脈-外腸骨静脈間の血流動態変化が一因と考えられた深部静脈血栓症の一例, 第108回日本循環器学会中国・四国合同地方会, Jun. 2016.
123.	Takayuki Ise, Shusuke Yagi, 門田宗之, 瀬野弘光, 西條良仁, 上野理絵, 原知也, 齋藤友子, 山﨑宙, 坂東左知子, 伊藤浩敬, 轟貴史, Tomomi Matsuura, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 循環器病棟入院患者における睡眠時無呼吸，夜間低酸素血症の合併 ∼連続パルスオキシメータを用いた解析∼, 第108回日本循環器学会中国・四国合同地方会, Jun. 2016.
124.	本間友佳子, Kazuhiro Mori, Keisuke Fujioka, 佐々木亜由美, 寺田知正, 永井隆, 井上美紀, Yasunobu Hayabuchi, 小野朱美, Shoji Kagami, Masataka Sata, Takeshi Soeki, Takeshi Tobiume and Tomomi Matsuura : 持続する全身倦怠感を主訴とした異所性心房頻拍に伴う頻拍誘発性心筋症の1女児例, 第146回日本小児科学会徳島地方会, Jun. 2016.
125.	Tomomi Matsuura, Takeshi Soeki, Takeshi Tobiume, 上野理絵, 坂東左知子, Hirotsugu Yamada, Tetsuzo Wakatsuki, Masataka Sata, Yasunobu Hayabuchi and 小野朱美 : 心房中隔起源の持続性心房頻拍により頻脈誘発性心筋症をきたした小児の1例, 日本内科学会第114回四国地方会, May 2016.
126.	Koji Yamaguchi, Tetsuzo Wakatsuki, T Hara, M Kadota, R Ueno, Mika Bando, H Yamazaki, Y Saito, S Bando, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Local Vascular Response after Paclitaxel Eluting Balloon Angioplasty Compared to Drug Eluting Stent Implantation in Stable Angina Patients., 第80回日本循環器学会学術集会, Mar. 2016.
127.	S Bando, Takeshi Soeki, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro and Masataka Sata : Plasma Myeloperoxidase Activity is Associated with Atrial Substrate Remodeling in Patients with Atrial Fibrillation., 第80回日本循環器学会学術集会, Mar. 2016.
128.	Tomomi Matsuura, Takeshi Soeki, Y Morimoto, S Bando, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro and Masataka Sata : Epicardial Adipose Tissue Produce Proinflammatory Cytokines and Influence the Pathogenesis of Atrial Fibrillation., 第80回日本循環器学会学術集会, Mar. 2016.
129.	加藤悠人, Takeshi Tobiume, 小島義裕, 川端豊, Toshiyuki Niki, 岡村暢大, Yoshio Taketani, 坂東左知子, Tomomi Matsuura, Takeshi Soeki and Masataka Sata : His束近傍に起源を認めるATP感受性心房頻拍7例に関する検討, 第252回徳島医学会学術集会(平成27年度冬期), Feb. 2016.
130.	近藤大祐, Shusuke Yagi, Takayuki Ise, Koji Yamaguchi, Tetsuzo Wakatsuki, Kenya Kusunose, Tomomi Matsuura, Takeshi Tobiume, Hirotsugu Yamada, Takeshi Soeki, Daiju Fukuda, Masashi Akaike, Michio Shimabukuro and Masataka Sata : 急性冠症候群発症時のイコサペント酸とドコサヘキサエン酸の血中濃度低下は慢性期冠動脈ステント内再狭窄の予測因子である, 第45回日本心脈管作動物質学会, Feb. 2016.
131.	上田雄大, Michio Shimabukuro, Maimaituxun Gulinu, Salim Masdan Hotimah, 坂東左知子, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Takashi Iwase, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masafumi Harada and Masataka Sata : 冠症候群発症例における心臓周囲脂肪および腹部脂肪分布の検討, 第45回日本心脈管作動物質学会, Feb. 2016.
132.	Maimaituxun Gulinu, Michio Shimabukuro, Salim Masdan Hotimah, Tomomi Matsuura, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Takeshi Soeki, 田端実, 森本喜久, 赤坂武, 田中正史, 高梨秀一郎 and Masataka Sata : 冠動脈疾患と心臓周囲脂肪量:男女差の検討, 第45回日本心脈管作動物質学会, Feb. 2016.
133.	G Maimaituxun, Michio Shimabukuro, HM Salim, Tomomi Matsuura, Shusuke Yagi, D Fukuda, Hirotsugu Yamada, Takeshi Soeki, M Tabata, Y Morimoto, T Akasaka, M Tanaka, S Takanashi and Masataka Sata : EATV is determinant for coronary atherosclerosis in men, but not in women: Analysis from patients underwent coronary artery bypass surgery., CVMW 2015, Dec. 2015.
134.	Takayuki Ise, 西條良仁, Hirokazu Miki, Kumiko Kagawa, 瀬野弘光, 上野理絵, 原知也, 齋藤友子, Mika Bando, 坂東左知子, 伊藤浩敬, Tomomi Matsuura, Koji Yamaguchi, Takeshi Tobiume, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masahiro Abe and Masataka Sata : auto-PBSCT とBortezomibの併用が著効した高度心機能障害を伴う原発性心アミロイドーシスの1例, 第107回日本循環器学会四国地方会, Nov. 2015.
135.	坂東左知子, Takeshi Soeki, Tomomi Matsuura, 飛梅威, 瀬野弘光, 西條良仁, 門田宗之, 原知也, 上野理絵, 齋藤友子, Mika Bando, 山﨑宙, 伊藤浩敬, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : 心室瘤を形成した心サルコイドーシス患者の薬剤抵抗性VT storm に対しアブレーションを行った一例, 第107回日本循環器学会四国地方会, Nov. 2015.
136.	伊藤浩敬, 高島啓, Shusuke Yagi, 瀬野弘光, 門田宗之, 原知也, 上野理絵, 齋藤友子, 山﨑宙, Mika Bando, 坂東左知子, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, 飛梅威, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 重症筋無力症に対する免疫抑制療法中に生じた化膿性心膜炎の一例, 第107回日本循環器学会四国地方会, Nov. 2015.
137.	近藤大祐, Shusuke Yagi, Takayuki Ise, Koji Yamaguchi, Tetsuzo Wakatsuki, Kenya Kusunose, Tomomi Matsuura, 飛梅威, Hirotsugu Yamada, Takeshi Soeki, Daiju Fukuda, 赤池雅史, 島袋充生 and Masataka Sata : 急性冠症候群患者におけるスタチンのω3不飽和脂肪酸濃度へ影響, 第107回日本循環器学会四国地方会, Nov. 2015.
138.	加藤悠人, 飛梅威, 坂東左知子, Tomomi Matsuura, Takeshi Soeki, 瀬野弘光, 上野理絵, 門田宗之, 原知也, 齋藤友子, 高島啓, 山﨑宙, Mika Bando, 伊藤浩敬, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : His束近傍に起源を認めるATP感受性心房頻拍7例に関する検討, 第107回日本循環器学会四国地方会, Nov. 2015.
139.	坂東左知子, Takeshi Tobiume, Takeshi Soeki, Tomomi Matsuura and Masataka Sata : 僧房弁輪後壁での通電にて治療に成功したLeft variant型房室結節リエントリー性頻拍の1例, カテーテルアブレーション関連秋季大会2015, Oct. 2015.
140.	Takeshi Tobiume, Yoshio Taketani, 小島義裕, 川端豊, Toshiyuki Niki, 岡村暢大, 坂東左知子, Tomomi Matsuura, Takeshi Soeki and Masataka Sata : 下壁誘導でtall R・V1でqrS patternを認めた右室流出路中隔起源心室性期外収縮の1例, カテーテルアブレーション関連秋季大会2015, Oct. 2015.
141.	長野広実, Takeshi Soeki, 坂東左知子, Tomomi Matsuura, Takeshi Tobiume, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro and Masataka Sata : 心房細動発症の予測因子-心電学的側面と心エコー学的側面からの検討-, 第63回日本心臓病学会学術集会, Sep. 2015.
142.	坂東左知子, Takeshi Soeki, 飛梅威, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : 薬剤抵抗性のPurkinje起源心室頻拍に対し，人工呼吸管理・PCPS装着下にカテーテルアブレーション治療を施行し，社会復帰に成功した若年例の一例, 第63回日本心臓病学会学術集会, Sep. 2015.
143.	Takayuki Ise, Kenya Kusunose, Tomomi Matsuura, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 急性心筋梗塞後にBeckerⅠ型とⅢ型の心破裂をきたし，救命しえた一例, 第63回日本心臓病学会学術集会, Sep. 2015.
144.	長野広実, Takeshi Soeki, 坂東左知子, Tomomi Matsuura, 飛梅威, Kenya Kusunose, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Hirotsugu Yamada, Tetsuzo Wakatsuki, 島袋充生 and Masataka Sata : 心房細動発症の予測因子-心電学的側面と心エコー学的側面からの検討-, 第63回日本心臓病学会学術集会, Sep. 2015.
145.	Takeshi Tobiume, S Bando, Tomomi Matsuura, Takeshi Soeki and Masataka Sata : Efficacy of CATHPAX AF for the reduction of radiation exposure during ablation of atrial fibrillation., 第30回日本不整脈学会・第32回日本心電学会, Jul. 2015.
146.	S Bando, Takeshi Soeki, Tomomi Matsuura, Takeshi Tobiume and Masataka Sata : Successful catheter ablation of VT/VF triggered by PVC in acute phase of myocardial infarction., 第30回日本不整脈学会・第32回日本心電学会, Jul. 2015.
147.	高島啓, 門田宗之, Koji Yamaguchi, 原知也, 齋藤友子, Mika Bando, 坂東左知子, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, 飛梅威, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : IgA腎症の加療中に若年で発症した急性冠症候群の一例, 第106回日本循環器学会中国・四国合同地方会, Jun. 2015.
148.	山﨑宙, Koji Yamaguchi, 原知也, 高島啓, Mika Bando, 齋藤友子, 坂東左知子, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, 飛梅威, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 右心不全を来した収縮性心膜炎合併心膜嚢胞の一例, 第106回日本循環器学会中国・四国合同地方会, Jun. 2015.
149.	山﨑宙, Shusuke Yagi, 鳥居裕太, 天野里江, 西尾進, 原知也, 齋藤友子, 高島啓, Mika Bando, 坂東左知子, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, 飛梅威, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, 島袋充生, 赤池雅史 and Masataka Sata : 深部静脈血栓症に対するエドキサバンの凝固因子に与える影響, 第106回日本循環器学会中国・四国合同地方会, Jun. 2015.
150.	山﨑宙, Shusuke Yagi, 原知也, 高島啓, Mika Bando, 齋藤友子, 坂東左知子, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, 飛梅威, Koji Yamaguchi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 家族性アミロイドポリニューロパチーを合併した心肥大の一例, 第106回日本循環器学会中国・四国合同地方会, Jun. 2015.
151.	坂東左知子, Takeshi Soeki, 原知也, 齋藤友子, Mika Bando, 山﨑宙, 高島啓, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, 飛梅威, Shusuke Yagi, Hirotsugu Yamada, Tetsuzo Wakatsuki, 坂東正章 and Masataka Sata : Brugada症候群に閉塞性肥大型心筋症を併発した一例, 第106回日本循環器学会中国・四国合同地方会, Jun. 2015.
152.	瀬野弘光, Mika Bando, Kenya Kusunose, Hirotsugu Yamada, 高川由利子, 林修司, 齋藤友子, 山﨑宙, 高島啓, 坂東左知子, Tomomi Matsuura, Takayuki Ise, 飛梅威, Koji Yamaguchi, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki, 平田有紀奈, 西尾進, 島袋充生 and Masataka Sata : CHADS2スコア低値例における左心耳機能の検討, 第106回日本循環器学会中国・四国合同地方会, Jun. 2015.
153.	飛梅威, 坂東左知子, Tomomi Matsuura, Takeshi Soeki, 今田久美子, 松本和久, 齋藤友子, 原知也, 高島啓, 山﨑宙, Mika Bando, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Tetsuzo Wakatsuki, 赤池雅史 and Masataka Sata : 心房細動カテーテルアブレーションにおける放射線防護キャビンの放射線被爆低減効果について, 第106回日本循環器学会中国・四国合同地方会, Jun. 2015.
154.	上野理絵, Mika Bando, Hirotsugu Yamada, Kenya Kusunose, 高川由利子, 瀬野弘光, 門田宗之, 原知也, 齋藤友子, 山﨑宙, 高島啓, 坂東左知子, Tomomi Matsuura, Takayuki Ise, 飛梅威, Koji Yamaguchi, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki, 島袋充生 and Masataka Sata : 間質性肺炎合併膠原病性肺高血圧症にボセンタンが奏功した1例, 第106回日本循環器学会中国・四国合同地方会, Jun. 2015.
155.	平田有紀奈, Hirotsugu Yamada, Kenya Kusunose, 西尾進, 山尾雅美, 天野里江, 鳥居裕太, 鈴川理乃, 高川由利子, Mika Bando, 林修司, 阿部美保, 坂東左知子, Tomomi Matsuura, 飛梅威, Takeshi Soeki and Masataka Sata : 心房細動に対する肺静脈隔離術後における洞調律維持の予測∼心エコー検査を用いた検討∼, 第106回日本循環器学会中国・四国合同地方会, Jun. 2015.
156.	坂東左知子, Tomomi Matsuura, Takeshi Soeki, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : 感染性心内膜炎から多発性脳塞栓発症により死亡に至った一例, 第2回日本心血管脳卒中学会学術集会, Jun. 2015.
157.	飛梅威, 坂東左知子, Tomomi Matsuura, Takeshi Soeki, 今田久美子, 松本和久, 原知也, 齋藤友子, 高島啓, 山﨑宙, Mika Bando, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Tetsuzo Wakatsuki, 赤池雅史 and Masataka Sata : 心房細動カテーテルアブレーションにおける放射線防護キャビンの放射線被爆低減効果に関する検討, 第2回日本心血管脳卒中学会学術集会, Jun. 2015.
158.	平田有紀奈, Hirotsugu Yamada, Kenya Kusunose, 西尾進, 山尾雅美, Mika Bando, Tomomi Matsuura, 飛梅威, Takeshi Soeki and Masataka Sata : 心房細動に対する肺静脈隔離術後における洞調律維持の予測:経胸壁および3次元経食道心エコー検査を用いた検討, 第2回日本心血管脳卒中学会学術集会, Jun. 2015.
159.	Koji Yamaguchi, Tetsuzo Wakatsuki, T Hara, Y Takagawa, Mika Bando, A Takashima, H Yamazaki, S Bando, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, Takeshi Tobiume, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : Differential Local Vascular Responses after Implantation of Biolimus-Eluting and Everolimus-Eluting Stents Compared with Sirolimus-Eluting and Bare Metal Stents., 第79回日本循環器学会学術集会, Apr. 2015.
160.	Takeshi Soeki, Tomomi Matsuura, S Bando, Takeshi Tobiume, T Hara, A Takashima, Mika Bando, H Yamazaki, Y Saito, Takayuki Ise, Kenya Kusunose, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Takashi Iwase, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro and Masataka Sata : Antiarrhythmic and Antiapoptotic Effects of C-type Natriuretic Peptide in Rats with Myocardial Ischemia/Reperfusion., 第79回日本循環器学会学術集会, Apr. 2015.
161.	武井美貴子, Takeshi Tobiume, 坂東左知子, Tomomi Matsuura, Takeshi Soeki and Masataka Sata : 生理的ペーシングへのモード変更が心不全の改善に有効であった房室ブロックの1例, 第7回植込みデバイス関連冬季大会, Feb. 2015.
162.	松本康平, Kenya Kusunose, 松本和久, 高川由利子, Mika Bando, Junko Hotsuchi, Tomomi Matsuura, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 動脈周囲炎をきたしたIgG4関連疾患の1例, 第250回徳島医学会学術集会(平成26年度冬期), Feb. 2015.
163.	鈴木智子, 山崎宙, 近藤彰, 高川由利子, Mika Bando, Junko Hotsuchi, Tomomi Matsuura, Kenya Kusunose, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 活動性を評価するにあたりPET-CTが特に有効であった心サルコイドーシスの1例, 第250回徳島医学会学術集会(平成26年度冬期), Feb. 2015.
164.	武井美貴子, Takeshi Tobiume, 坂東左知子, Tomomi Matsuura, Takeshi Soeki, 今田久美子, 松本和久, 高川由利子, 原知也, 高島啓, 齋藤友子, 山崎宙, Mika Bando, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : 生理的ペーシングへのモード変更が心不全の改善に有効であった房室ブロックの1例, 第250回徳島医学会学術集会(平成26年度冬期), Feb. 2015.
165.	今田久美子, Takayuki Ise, Shusuke Yagi, 高木恵理, 松本和久, 高川由利子, 原知也, 高島啓, 齋藤友子, Mika Bando, 山﨑宙, 坂東左知子, Tomomi Matsuura, Takeshi Tobiume, Koji Yamaguchi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masashi Akaike and Masataka Sata : 慢性血栓塞栓性肺高血圧症にリオシグアトを使用した1症例, 第105回日本循環器学会四国地方会, Dec. 2014.
166.	Takayuki Ise, Takashi Iwase, 高木恵理, 今田久美子, 松本和久, 高川由利子, 原知也, 齋藤友子, 高島啓, 山﨑宙, Mika Bando, 坂東左知子, Tomomi Matsuura, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 心臓MRIガドリニウム遅延造影で検出できなかった心臓サルコイドーシス再燃の一例, 第105回日本循環器学会四国地方会, Dec. 2014.
167.	高島啓, Tetsuzo Wakatsuki, Koji Yamaguchi, 松本和久, 今田久美子, 高木恵理, 高川由利子, 原知也, 齋藤友子, 山﨑宙, Mika Bando, 坂東左知子, Tomomi Matsuura, Takayuki Ise, Takeshi Tobiume, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : 冠動脈完全閉塞性病変の治療後慢性期に形成された二重血行路をOCTで観察し得た一例, 第105回日本循環器学会四国地方会, Dec. 2014.
168.	坂東左知子, Takeshi Soeki, 今田久美子, 松本和久, 原知也, 高島啓, 山﨑宙, Mika Bando, 齋藤友子, Tomomi Matsuura, Takayuki Ise, Kenya Kusunose, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : 右室流出路心外膜起源が疑われた突発性心室期外収縮の一例, 第105回日本循環器学会四国地方会, Dec. 2014.
169.	富永真由, Takayuki Ise, Mika Bando, 今田久美子, 松本和久, 高川由利子, 原知也, 齋藤友子, 高島啓, 山﨑宙, 坂東左知子, Tomomi Matsuura, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, 坂東正章 and Masataka Sata : 超選択的コントラストエコーを併用し経皮的中隔心筋焼灼術を有効に施行し得た閉塞性肥大型心筋症の1例, 第105回日本循環器学会四国地方会, Dec. 2014.
170.	高川由利子, 林修司, Hirotsugu Yamada, Mika Bando, 天野里江, 西尾進, 山尾雅美, Tomomi Matsuura and Masataka Sata : ペースメーカー植込み術後より聴取された収縮期雑音の診断に3次元心エコー図検査が有用であった一例, 第24回日本超音波医学会四国地方会学術集会, Oct. 2014.
171.	Tomomi Matsuura, Takeshi Soeki, 西條良仁, 齋藤友子, 高島啓, Mika Bando, 坂東左知子, Junko Hotsuchi, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : 筋強直性ジストロフィーに伴い二次性心筋症と心房頻拍を呈し，カテーテルアブレーションを施行した一例, 第62回日本心臓病学会学術集会, Sep. 2014.
172.	坂東左知子, Takeshi Soeki, Takeshi Tobiume, Tomomi Matsuura, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : ATP 感受性リエントリー性心房頻拍の2症例, 第62回日本心臓病学会学術集会, Sep. 2014.
173.	Takeshi Soeki, 坂東左知子, Tomomi Matsuura, Takeshi Tobiume, 高島啓, Mika Bando, Junko Hotsuchi, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Takashi Iwase, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro and Masataka Sata : 心房細動におけるmicroRNAと心房リモデリングおよび予後との関係, 第62回日本心臓病学会学術集会, Sep. 2014.
174.	富永真由, Takayuki Ise, Mika Bando, 今田久美子, 松本和久, 高川由利子, 高木恵理, 西條良仁, 原知也, 齋藤友子, 高島啓, 山﨑宙, 坂東左知子, Tomomi Matsuura, Junko Hotsuchi, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, 坂東正章 and Masataka Sata : 超選択的コントラストエコーを併用し経皮的中隔心筋焼灼術を有効に施行し得た閉塞性肥大型心筋症の一例, 第249回徳島医学会学術集会(平成26年度夏期), Jul. 2014.
175.	亀田香奈子, Takayuki Ise, 西條良仁, 今田久美子, 松本和久, 高川由利子, 高木恵理, 原知也, 齋藤友子, 高島啓, 山﨑宙, Mika Bando, 坂東左知子, Tomomi Matsuura, Junko Hotsuchi, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, 近藤剛 and Masataka Sata : 原発性アルドステロン症患者に高度冠攣縮を合併し心筋梗塞を発症した1症例, 第249回徳島医学会学術集会(平成26年度夏期), Jul. 2014.
176.	S Bando, Takeshi Soeki, Takeshi Tobiume, Tomomi Matsuura and Masataka Sata : Radiofrequency ablation of idiopathic premature ventricular contraction originating from the anterior papillary muscle in the left ventricle., 第29回日本不整脈学会・第31回日本心電学会合同学術大会, Jul. 2014.
177.	Tomomi Matsuura, Takeshi Soeki, Takeshi Tobiume, S Bando and Masataka Sata : A case of myotonic dystrophy presenting with atrial tachycardia and heart failure., 第29回日本不整脈学会・第31回日本心電学会合同学術大会, Jul. 2014.
178.	Takeshi Soeki, S Bando, Tomomi Matsuura, Takeshi Tobiume and Masataka Sata : Electrophysiological correlation and prognostic impact of pentraxin 3 as a local inflammatory marker in atrial fibrillation., 第29回日本不整脈学会・第31回日本心電学会合同学術集会, Jul. 2014.
179.	西條良仁, Takayuki Ise, Hirokazu Miki, Kumiko Kagawa, 原知也, 齋藤友子, 高島啓, Mika Bando, 坂東左知子, Tomomi Matsuura, Junko Hotsuchi, Koji Yamaguchi, Takeshi Tobiume, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, 奥村宇信, 藤永裕之 and Masataka Sata : 高度心機能障害を伴う原発性心アミロイドーシスに対しauto-PBSCTを施行し得た一例, 第104回日本循環器学会中国・四国合同地方会, Jul. 2014.
180.	澤田直子, 高川由利子, Junko Hotsuchi, 西條良仁, 高島啓, Mika Bando, 山崎宙, 坂東左知子, Tomomi Matsuura, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 心エコー検査による大動脈弁逆流の重症度判定が困難であった大動脈弁位生体弁機能不全の一例, 第104回日本循環器学会中国・四国合同地方会, Jul. 2014.
181.	坂東左知子, Takeshi Soeki, Takeshi Tobiume, Tomomi Matsuura, 今田久美子, 松本和久, 高木恵理, 西條良仁, 原知也, 齋藤友子, 高島啓, Mika Bando, 山崎宙, Takayuki Ise, Junko Hotsuchi, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : ATP感受性リエントリー性心房頻拍の一例, 第104回日本循環器学会中国・四国合同地方会, Jul. 2014.
182.	Tomomi Matsuura, Takeshi Soeki, 松本和久, 今田久美子, 西條良仁, 高木恵理, 原知也, 齋藤友子, 高島啓, Mika Bando, 山崎宙, 坂東左知子, Junko Hotsuchi, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Tetsuzo Wakatsuki and Masataka Sata : 心房頻拍と心不全を契機に発覚した筋強直性ジストロフィーの一例, 第104回日本循環器学会中国・四国合同地方会, Jul. 2014.
183.	坂東左知子, Takeshi Soeki, Takeshi Tobiume, Tomomi Matsuura, 齋藤友子, 高島啓, Mika Bando, 山崎宙, Takayuki Ise, Junko Hotsuchi, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Tetsuzo Wakatsuki, Miho Sakata, Yasunobu Hayabuchi, 井上美紀, Kazuhiro Mori, 木下学 and Masataka Sata : 薬剤抵抗性特発性心室頻拍に対し，PCPS下にアブレーション治療を施行し，社会復帰に成功した若年例の一例, 第104回日本循環器学会中国・四国合同地方会, Jul. 2014.
184.	松本和久, Tetsuzo Wakatsuki, 高島啓, Koji Yamaguchi, 西條良仁, 高木恵理, 原知也, 齋藤友子, 高川由利子, 山崎宙, Mika Bando, 坂東左知子, Tomomi Matsuura, Takayuki Ise, Junko Hotsuchi, Takeshi Tobiume, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki and Masataka Sata : シロリムス溶出ステント留置7年後に初めて造影剤ステント周囲滲み出し像と局所凝固反応亢進を認めた一例, 第104回日本循環器学会中国・四国合同地方会, Jul. 2014.
185.	今田久美子, Takayuki Ise, 原知也, Shusuke Yagi, Takashi Iwase, 西條良仁, 小笠原梢, 高島啓, Mika Bando, 坂東左知子, Tomomi Matsuura, Junko Hotsuchi, Takeshi Tobiume, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masashi Akaike and Masataka Sata : 心不全を合併した頻脈性心房細動にランジオロールを有効に使用することができた2症例, 第104回日本循環器学会中国・四国合同地方会, Jul. 2014.
186.	坂東左知子, Takeshi Soeki, Takeshi Tobiume, Tomomi Matsuura, Koji Yamaguchi, Hirotsugu Yamada, Tetsuzo Wakatsuki, Masataka Sata, 井野口卓 and 折野俊介 : 左室前乳頭筋起源の特発性心室性不整脈の1例, 第110回日本内科学会四国地方会, Jun. 2014.
187.	Tomomi Matsuura, Takeshi Soeki, Koji Yamaguchi, Shusuke Yagi, Daiju Fukuda, Takashi Iwase, Hirotsugu Yamada, Tetsuzo Wakatsuki, Michio Shimabukuro and Masataka Sata : 心房高頻度刺激を行った糖尿病モデルラットにおける直接レニン阻害薬の内皮機能障害抑制効果, 第1回日本心血管脳卒中学会学術集会, Jun. 2014.

Products:

1.	Shusuke Yagi, Daiju Fukuda, Yukina Hirata, Ganbaatar Byambasuren, Arief Rahadian, Takayuki Ise, Kenya Kusunose, Hirotsugu Yamada, Koji Yamaguchi, Tomomi Matsuura, Takeshi Tobiume, Tomohiro Soga, Takeshi Soeki, Tetsuzo Wakatsuki, Shinji Kawahito and Masataka Sata : 【糖尿病専門医に必要な心不全の知識update】SGLT2阻害薬と心不全(解説/特集), 糖尿病・内分泌代謝科, Vol.52, No.3, 257-264, Nov. 2021.

Et cetera, Workshop:

1.	村上貴寛, Shusuke Yagi, 原知也, Takayuki Ise, Kenya Kusunose, Tomomi Matsuura, Takeshi Tobiume, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Michio Shimabukuro, Masashi Akaike, 春藤譲治 and Masataka Sata : 原発性アルドステロン症の診断に有用な臨床所見の検討, 第253回徳島医学会学術集会(平成28年度夏期), Jul. 2016.
2.	山上圭, 西條良仁, Kenya Kusunose, Hirotsugu Yamada, 瀬野弘光, 原知也, 上野理絵, 門田宗之, 齋藤友子, 山﨑宙, 坂東左知子, 伊藤浩敬, 轟貴史, Tomomi Matsuura, Takayuki Ise, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata : 生体腎移植後における腎静脈-外腸骨静脈間の血流動態変化が一因と考えられた深部静脈血栓症の一例, 第253回徳島医学会学術集会(平成28年度夏期), Jul. 2016.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

Search by Researcher Number (70645184)

Assistant Professor : Matsuura, Tomomi

Research

Field of Study

Subject of Study

Book / Paper

Book:

Academic Paper (Judged Full Paper):

Proceeding of International Conference:

Proceeding of Domestic Conference:

Products:

Et cetera, Workshop:

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)